"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","characteristics_ch1.8","characteristics_ch1.9","characteristics_ch1.10","characteristics_ch1.11","characteristics_ch1.12","characteristics_ch1.13","characteristics_ch1.14","characteristics_ch1.15","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","supplementary_file.1","supplementary_file.2","supplementary_file.3","supplementary_file.4","supplementary_file.5","data_row_count"
"GSM268530","Patient 336 Core Set (custom panel)","GSM268530","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 3.2","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.1047227926078","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-336","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268530/GSM268530_1557311034_R002_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268530/GSM268530_1557311034_R002_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268530/GSM268530_1557311034_R002_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268530/GSM268530_1557311034_R002_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268530/GSM268530_1557311034_R002_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268530/GSM268530_1557311034_R002_C007_Red.xml.gz","526"
"GSM268531","Patient 345 Core Set (custom panel)","GSM268531","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 6","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.13073237508556","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-345","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268531/GSM268531_1557311034_R002_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268531/GSM268531_1557311034_R002_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268531/GSM268531_1557311034_R002_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268531/GSM268531_1557311034_R002_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268531/GSM268531_1557311034_R002_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268531/GSM268531_1557311034_R002_C008_Red.xml.gz","526"
"GSM268532","Patient 353 Core Set (custom panel)","GSM268532","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 11.4","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: NA","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 3.90143737166324","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 5.30047912388775","PSA Slope (ng/ml/yr): 0.0714774951076321","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.145106091718","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-353","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268532/GSM268532_1557311034_R002_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268532/GSM268532_1557311034_R002_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268532/GSM268532_1557311034_R002_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268532/GSM268532_1557311034_R002_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268532/GSM268532_1557311034_R002_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268532/GSM268532_1557311034_R002_C009_Red.xml.gz","526"
"GSM268533","Patient 361 Core Set (custom panel)","GSM268533","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 9.9","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.9650924024641","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-361","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268533/GSM268533_1557311034_R002_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268533/GSM268533_1557311034_R002_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268533/GSM268533_1557311034_R002_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268533/GSM268533_1557311034_R002_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268533/GSM268533_1557311034_R002_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268533/GSM268533_1557311034_R002_C010_Red.xml.gz","526"
"GSM268534","Patient 374 Core Set (custom panel)","GSM268534","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 2.4","Revised Gleason Score: 7","Stage: TxN+","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to first rising PSA: 2.81724845995893","Second Rising PSA (ng/ml): 1","Time (yrs) from RRP to second rising PSA: 3.15947980835044","PSA Slope (ng/ml/yr): 1.1688","Time (yrs) from PSA recurrence to systemic disease: 0.577686516084873","Years of Followup after RRP: 5.93292265571526","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-374","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268534/GSM268534_1557311034_R002_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268534/GSM268534_1557311034_R002_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268534/GSM268534_1557311034_R002_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268534/GSM268534_1557311034_R002_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268534/GSM268534_1557311034_R002_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268534/GSM268534_1557311034_R002_C012_Red.xml.gz","526"
"GSM268535","Patient 008 Core Set (custom panel)","GSM268535","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 4.5","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.4934976043806","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-008","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268535/GSM268535_1557311034_R003_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268535/GSM268535_1557311034_R003_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268535/GSM268535_1557311034_R003_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268535/GSM268535_1557311034_R003_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268535/GSM268535_1557311034_R003_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268535/GSM268535_1557311034_R003_C001_Red.xml.gz","526"
"GSM268536","Patient 296 Core Set (custom panel)","GSM268536","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 11","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 1.1","Time (yrs) from RRP to first rising PSA: 0.249144421629021","Second Rising PSA (ng/ml): 2.2","Time (yrs) from RRP to second rising PSA: 0.509240246406571","PSA Slope (ng/ml/yr): 4.22921052631579","Time (yrs) from PSA recurrence to systemic disease: 0.58590006844627","Years of Followup after RRP: 16.1560574948665","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-296","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268536/GSM268536_1557311034_R003_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268536/GSM268536_1557311034_R003_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268536/GSM268536_1557311034_R003_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268536/GSM268536_1557311034_R003_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268536/GSM268536_1557311034_R003_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268536/GSM268536_1557311034_R003_C002_Red.xml.gz","526"
"GSM268537","Patient 304 Core Set (custom panel)","GSM268537","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 7.8","Revised Gleason Score: 6","Stage: T2N0","Ploidy: NA","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.92128678987","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-304","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268537/GSM268537_1557311034_R003_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268537/GSM268537_1557311034_R003_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268537/GSM268537_1557311034_R003_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268537/GSM268537_1557311034_R003_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268537/GSM268537_1557311034_R003_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268537/GSM268537_1557311034_R003_C003_Red.xml.gz","526"
"GSM268538","Patient 313 Core Set (custom panel)","GSM268538","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 7.4","Revised Gleason Score: 6","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.6331279945243","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-313","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268538/GSM268538_1557311034_R003_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268538/GSM268538_1557311034_R003_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268538/GSM268538_1557311034_R003_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268538/GSM268538_1557311034_R003_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268538/GSM268538_1557311034_R003_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268538/GSM268538_1557311034_R003_C004_Red.xml.gz","526"
"GSM268539","Patient 321 Core Set (custom panel)","GSM268539","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 1.1","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.9911019849418","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-321","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268539/GSM268539_1557311034_R003_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268539/GSM268539_1557311034_R003_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268539/GSM268539_1557311034_R003_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268539/GSM268539_1557311034_R003_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268539/GSM268539_1557311034_R003_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268539/GSM268539_1557311034_R003_C005_Red.xml.gz","526"
"GSM268540","Patient 329 Core Set (custom panel)","GSM268540","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 7.1","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 1.8425735797399","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 2.14647501711157","PSA Slope (ng/ml/yr): 0.263243243243243","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.27446954140999","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-329","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268540/GSM268540_1557311034_R003_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268540/GSM268540_1557311034_R003_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268540/GSM268540_1557311034_R003_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268540/GSM268540_1557311034_R003_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268540/GSM268540_1557311034_R003_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268540/GSM268540_1557311034_R003_C006_Red.xml.gz","526"
"GSM268541","Patient 337 Core Set (custom panel)","GSM268541","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 79","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: NA","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.862422997946612","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 1.57426420260096","PSA Slope (ng/ml/yr): 0.702403846153846","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 17.3004791238877","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-337","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268541/GSM268541_1557311034_R003_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268541/GSM268541_1557311034_R003_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268541/GSM268541_1557311034_R003_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268541/GSM268541_1557311034_R003_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268541/GSM268541_1557311034_R003_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268541/GSM268541_1557311034_R003_C007_Red.xml.gz","526"
"GSM268542","Patient 346 Core Set (custom panel)","GSM268542","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 10.4","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.29226557152635","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 1.67282683093771","PSA Slope (ng/ml/yr): 0.262769784172662","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.5126625598905","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-346","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268542/GSM268542_1557311034_R003_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268542/GSM268542_1557311034_R003_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268542/GSM268542_1557311034_R003_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268542/GSM268542_1557311034_R003_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268542/GSM268542_1557311034_R003_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268542/GSM268542_1557311034_R003_C008_Red.xml.gz","526"
"GSM268543","Patient 354 Core Set (custom panel)","GSM268543","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 55","PSA (ng/ml) at RRP: 8","Revised Gleason Score: 9","Stage: TxN+","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 4.33675564681725","Second Rising PSA (ng/ml): 0.85","Time (yrs) from RRP to second rising PSA: 4.65982203969884","PSA Slope (ng/ml/yr): 1.0833686440678","Time (yrs) from PSA recurrence to systemic disease: 2.81177275838467","Years of Followup after RRP: 8.87337440109514","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-354","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268543/GSM268543_1557311034_R003_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268543/GSM268543_1557311034_R003_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268543/GSM268543_1557311034_R003_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268543/GSM268543_1557311034_R003_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268543/GSM268543_1557311034_R003_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268543/GSM268543_1557311034_R003_C009_Red.xml.gz","526"
"GSM268544","Patient 369 Core Set (custom panel)","GSM268544","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 87.3","Revised Gleason Score: 9","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.208076659822","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-369","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268544/GSM268544_1557311034_R003_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268544/GSM268544_1557311034_R003_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268544/GSM268544_1557311034_R003_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268544/GSM268544_1557311034_R003_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268544/GSM268544_1557311034_R003_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268544/GSM268544_1557311034_R003_C011_Red.xml.gz","526"
"GSM268545","Patient 016 Core Set (custom panel)","GSM268545","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 5","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.35797399041752","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-016","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268545/GSM268545_1557311034_R004_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268545/GSM268545_1557311034_R004_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268545/GSM268545_1557311034_R004_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268545/GSM268545_1557311034_R004_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268545/GSM268545_1557311034_R004_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268545/GSM268545_1557311034_R004_C001_Red.xml.gz","526"
"GSM268546","Patient 297 Core Set (custom panel)","GSM268546","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 5.4","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.24","Time (yrs) from RRP to first rising PSA: 2.62012320328542","Second Rising PSA (ng/ml): 0.32","Time (yrs) from RRP to second rising PSA: 2.83915126625599","PSA Slope (ng/ml/yr): 0.36525","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.34976043805613","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-297","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268546/GSM268546_1557311034_R004_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268546/GSM268546_1557311034_R004_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268546/GSM268546_1557311034_R004_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268546/GSM268546_1557311034_R004_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268546/GSM268546_1557311034_R004_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268546/GSM268546_1557311034_R004_C002_Red.xml.gz","526"
"GSM268547","Patient 305 Core Set (custom panel)","GSM268547","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 8.6","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.9144421629021","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-305","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268547/GSM268547_1557311034_R004_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268547/GSM268547_1557311034_R004_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268547/GSM268547_1557311034_R004_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268547/GSM268547_1557311034_R004_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268547/GSM268547_1557311034_R004_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268547/GSM268547_1557311034_R004_C003_Red.xml.gz","526"
"GSM268548","Patient 314 Core Set (custom panel)","GSM268548","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 10.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.83162217659138","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 3.04722792607803","PSA Slope (ng/ml/yr): 0.0822635135135135","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.4106776180698","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-314","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268548/GSM268548_1557311034_R004_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268548/GSM268548_1557311034_R004_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268548/GSM268548_1557311034_R004_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268548/GSM268548_1557311034_R004_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268548/GSM268548_1557311034_R004_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268548/GSM268548_1557311034_R004_C004_Red.xml.gz","526"
"GSM268549","Patient 322 Core Set (custom panel)","GSM268549","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 56","PSA (ng/ml) at RRP: 2.8","Revised Gleason Score: 6","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.31074606433949","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 2.46132785763176","PSA Slope (ng/ml/yr): 1.32818181818182","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.76659822039699","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-322","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268549/GSM268549_1557311034_R004_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268549/GSM268549_1557311034_R004_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268549/GSM268549_1557311034_R004_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268549/GSM268549_1557311034_R004_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268549/GSM268549_1557311034_R004_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268549/GSM268549_1557311034_R004_C005_Red.xml.gz","526"
"GSM268550","Patient 330 Core Set (custom panel)","GSM268550","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 3.1","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.32","Time (yrs) from RRP to first rising PSA: 2.69952087611225","Second Rising PSA (ng/ml): 0.54","Time (yrs) from RRP to second rising PSA: 3.20328542094456","PSA Slope (ng/ml/yr): 0.436711956521739","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.29774127310062","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-330","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268550/GSM268550_1557311034_R004_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268550/GSM268550_1557311034_R004_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268550/GSM268550_1557311034_R004_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268550/GSM268550_1557311034_R004_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268550/GSM268550_1557311034_R004_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268550/GSM268550_1557311034_R004_C006_Red.xml.gz","526"
"GSM268551","Patient 338 Core Set (custom panel)","GSM268551","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 9.5","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.323066392881588","Second Rising PSA (ng/ml): 2","Time (yrs) from RRP to second rising PSA: 0.610540725530459","PSA Slope (ng/ml/yr): 6.26142857142857","Time (yrs) from PSA recurrence to systemic disease: 0.339493497604381","Years of Followup after RRP: 7.87679671457906","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-338","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268551/GSM268551_1557311034_R004_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268551/GSM268551_1557311034_R004_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268551/GSM268551_1557311034_R004_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268551/GSM268551_1557311034_R004_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268551/GSM268551_1557311034_R004_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268551/GSM268551_1557311034_R004_C007_Red.xml.gz","526"
"GSM268552","Patient 347 Core Set (custom panel)","GSM268552","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 75","PSA (ng/ml) at RRP: 11.5","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 1.3","Time (yrs) from RRP to first rising PSA: 1.57152635181383","Second Rising PSA (ng/ml): 2.7","Time (yrs) from RRP to second rising PSA: 1.70020533880904","PSA Slope (ng/ml/yr): 10.8797872340426","Time (yrs) from PSA recurrence to systemic disease: 4.90622861054073","Years of Followup after RRP: 7.53456536618754","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-347","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268552/GSM268552_1557311034_R004_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268552/GSM268552_1557311034_R004_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268552/GSM268552_1557311034_R004_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268552/GSM268552_1557311034_R004_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268552/GSM268552_1557311034_R004_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268552/GSM268552_1557311034_R004_C008_Red.xml.gz","526"
"GSM268553","Patient 355 Core Set (custom panel)","GSM268553","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 61","PSA (ng/ml) at RRP: 8.4","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.24435318275154","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-355","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268553/GSM268553_1557311034_R004_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268553/GSM268553_1557311034_R004_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268553/GSM268553_1557311034_R004_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268553/GSM268553_1557311034_R004_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268553/GSM268553_1557311034_R004_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268553/GSM268553_1557311034_R004_C009_Red.xml.gz","526"
"GSM268554","Patient 363 Core Set (custom panel)","GSM268554","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 6.3","Revised Gleason Score: 6","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.71937029431896","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 1.84804928131417","PSA Slope (ng/ml/yr): 2.3313829787234","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.0396988364134","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-363","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268554/GSM268554_1557311034_R004_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268554/GSM268554_1557311034_R004_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268554/GSM268554_1557311034_R004_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268554/GSM268554_1557311034_R004_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268554/GSM268554_1557311034_R004_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268554/GSM268554_1557311034_R004_C010_Red.xml.gz","526"
"GSM268555","Patient 370 Core Set (custom panel)","GSM268555","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 3.9","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.36002737850787","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 2.77618069815195","PSA Slope (ng/ml/yr): 0.240296052631579","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.170431211499","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-370","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268555/GSM268555_1557311034_R004_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268555/GSM268555_1557311034_R004_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268555/GSM268555_1557311034_R004_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268555/GSM268555_1557311034_R004_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268555/GSM268555_1557311034_R004_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268555/GSM268555_1557311034_R004_C011_Red.xml.gz","526"
"GSM268556","Patient 375 Core Set (custom panel)","GSM268556","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: 15.7","Revised Gleason Score: 8","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 0.476386036960986","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 0.930869267624914","PSA Slope (ng/ml/yr): 0.660090361445783","Time (yrs) from PSA recurrence to systemic disease: 10.0862422997947","Years of Followup after RRP: 14.6091718001369","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-375","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268556/GSM268556_1557311034_R004_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268556/GSM268556_1557311034_R004_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268556/GSM268556_1557311034_R004_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268556/GSM268556_1557311034_R004_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268556/GSM268556_1557311034_R004_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268556/GSM268556_1557311034_R004_C012_Red.xml.gz","526"
"GSM268557","Patient 028 Core Set (custom panel)","GSM268557","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 2.1","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.5886379192334","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-028","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268557/GSM268557_1557311034_R005_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268557/GSM268557_1557311034_R005_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268557/GSM268557_1557311034_R005_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268557/GSM268557_1557311034_R005_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268557/GSM268557_1557311034_R005_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268557/GSM268557_1557311034_R005_C001_Red.xml.gz","526"
"GSM268558","Patient 298 Core Set (custom panel)","GSM268558","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 7.1","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.1642710472279","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-298","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268558/GSM268558_1557311034_R005_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268558/GSM268558_1557311034_R005_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268558/GSM268558_1557311034_R005_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268558/GSM268558_1557311034_R005_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268558/GSM268558_1557311034_R005_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268558/GSM268558_1557311034_R005_C002_Red.xml.gz","526"
"GSM268559","Patient 306 Core Set (custom panel)","GSM268559","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 10.1","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: NA","First Rising PSA (ng/ml): 38.69","Time (yrs) from RRP to first rising PSA: 6.12183436002738","Second Rising PSA (ng/ml): 88.9","Time (yrs) from RRP to second rising PSA: 6.98425735797399","PSA Slope (ng/ml/yr): 58.2196904761905","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.1471594798083","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-306","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268559/GSM268559_1557311034_R005_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268559/GSM268559_1557311034_R005_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268559/GSM268559_1557311034_R005_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268559/GSM268559_1557311034_R005_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268559/GSM268559_1557311034_R005_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268559/GSM268559_1557311034_R005_C003_Red.xml.gz","526"
"GSM268560","Patient 315 Core Set (custom panel)","GSM268560","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 8.4","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.0616016427105","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-315","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268560/GSM268560_1557311034_R005_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268560/GSM268560_1557311034_R005_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268560/GSM268560_1557311034_R005_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268560/GSM268560_1557311034_R005_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268560/GSM268560_1557311034_R005_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268560/GSM268560_1557311034_R005_C004_Red.xml.gz","526"
"GSM268561","Patient 323 Core Set (custom panel)","GSM268561","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 61","PSA (ng/ml) at RRP: 15","Revised Gleason Score: 9","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 6.90212183436003","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 7.34565366187543","PSA Slope (ng/ml/yr): 0.225462962962963","Time (yrs) from PSA recurrence to systemic disease: 3.55920602327173","Years of Followup after RRP: 14.2724161533196","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-323","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268561/GSM268561_1557311034_R005_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268561/GSM268561_1557311034_R005_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268561/GSM268561_1557311034_R005_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268561/GSM268561_1557311034_R005_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268561/GSM268561_1557311034_R005_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268561/GSM268561_1557311034_R005_C005_Red.xml.gz","526"
"GSM268562","Patient 331 Core Set (custom panel)","GSM268562","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 10.6","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.44832306639288","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 2.73511293634497","PSA Slope (ng/ml/yr): 0.0777127659574468","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.7344284736482","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-331","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268562/GSM268562_1557311034_R005_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268562/GSM268562_1557311034_R005_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268562/GSM268562_1557311034_R005_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268562/GSM268562_1557311034_R005_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268562/GSM268562_1557311034_R005_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268562/GSM268562_1557311034_R005_C006_Red.xml.gz","526"
"GSM268563","Patient 339 Core Set (custom panel)","GSM268563","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 7","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 1.4","Time (yrs) from RRP to first rising PSA: 4.01642710472279","Second Rising PSA (ng/ml): 3.3","Time (yrs) from RRP to second rising PSA: 4.13963039014374","PSA Slope (ng/ml/yr): 15.4216666666667","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.280629705681","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-339","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268563/GSM268563_1557311034_R005_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268563/GSM268563_1557311034_R005_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268563/GSM268563_1557311034_R005_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268563/GSM268563_1557311034_R005_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268563/GSM268563_1557311034_R005_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268563/GSM268563_1557311034_R005_C007_Red.xml.gz","526"
"GSM268564","Patient 348 Core Set (custom panel)","GSM268564","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 7.2","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 0.232717316906229","Second Rising PSA (ng/ml): 0.8","Time (yrs) from RRP to second rising PSA: 0.632443531827515","PSA Slope (ng/ml/yr): 1.25085616438356","Time (yrs) from PSA recurrence to systemic disease: 3.33196440793977","Years of Followup after RRP: 9.42915811088296","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-348","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268564/GSM268564_1557311034_R005_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268564/GSM268564_1557311034_R005_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268564/GSM268564_1557311034_R005_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268564/GSM268564_1557311034_R005_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268564/GSM268564_1557311034_R005_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268564/GSM268564_1557311034_R005_C008_Red.xml.gz","526"
"GSM268565","Patient 356 Core Set (custom panel)","GSM268565","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 13.3","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 2.1","Time (yrs) from RRP to first rising PSA: 0.342231348391513","Second Rising PSA (ng/ml): 3.2","Time (yrs) from RRP to second rising PSA: 0.629705681040383","PSA Slope (ng/ml/yr): 3.82642857142857","Time (yrs) from PSA recurrence to systemic disease: 0.766598220396988","Years of Followup after RRP: 15.4387405886379","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-356","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268565/GSM268565_1557311034_R005_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268565/GSM268565_1557311034_R005_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268565/GSM268565_1557311034_R005_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268565/GSM268565_1557311034_R005_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268565/GSM268565_1557311034_R005_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268565/GSM268565_1557311034_R005_C009_Red.xml.gz","526"
"GSM268566","Patient 364 Core Set (custom panel)","GSM268566","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 8.3","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.8131416837782","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-364","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268566/GSM268566_1557311034_R005_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268566/GSM268566_1557311034_R005_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268566/GSM268566_1557311034_R005_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268566/GSM268566_1557311034_R005_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268566/GSM268566_1557311034_R005_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268566/GSM268566_1557311034_R005_C010_Red.xml.gz","526"
"GSM268567","Patient 371 Core Set (custom panel)","GSM268567","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 27.8","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.6290212183436","Second Rising PSA (ng/ml): 1.5","Time (yrs) from RRP to second rising PSA: 2.37645448323066","PSA Slope (ng/ml/yr): 1.73928571428571","Time (yrs) from PSA recurrence to systemic disease: 0.731006160164271","Years of Followup after RRP: 5.42642026009583","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-371","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268567/GSM268567_1557311034_R005_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268567/GSM268567_1557311034_R005_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268567/GSM268567_1557311034_R005_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268567/GSM268567_1557311034_R005_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268567/GSM268567_1557311034_R005_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268567/GSM268567_1557311034_R005_C011_Red.xml.gz","526"
"GSM268568","Patient 376 Core Set (custom panel)","GSM268568","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 9.4","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.13894592744695","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-376","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268568/GSM268568_1557311034_R005_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268568/GSM268568_1557311034_R005_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268568/GSM268568_1557311034_R005_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268568/GSM268568_1557311034_R005_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268568/GSM268568_1557311034_R005_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268568/GSM268568_1557311034_R005_C012_Red.xml.gz","526"
"GSM268569","Patient 034 Core Set (custom panel)","GSM268569","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 1.9","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.0171115674196","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-034","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268569/GSM268569_1557311034_R006_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268569/GSM268569_1557311034_R006_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268569/GSM268569_1557311034_R006_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268569/GSM268569_1557311034_R006_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268569/GSM268569_1557311034_R006_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268569/GSM268569_1557311034_R006_C001_Red.xml.gz","526"
"GSM268570","Patient 299 Core Set (custom panel)","GSM268570","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 12.3","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.1492128678987","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 2.65023956194387","PSA Slope (ng/ml/yr): 0.598770491803279","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.4517453798768","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-299","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268570/GSM268570_1557311034_R006_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268570/GSM268570_1557311034_R006_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268570/GSM268570_1557311034_R006_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268570/GSM268570_1557311034_R006_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268570/GSM268570_1557311034_R006_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268570/GSM268570_1557311034_R006_C002_Red.xml.gz","526"
"GSM268571","Patient 316 Core Set (custom panel)","GSM268571","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 13.3","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 4.25188227241615","Second Rising PSA (ng/ml): 1.8","Time (yrs) from RRP to second rising PSA: 5.30869267624914","PSA Slope (ng/ml/yr): 1.32474093264249","Time (yrs) from PSA recurrence to systemic disease: 1.30047912388775","Years of Followup after RRP: 9.96303901437372","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-316","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268571/GSM268571_1557311034_R006_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268571/GSM268571_1557311034_R006_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268571/GSM268571_1557311034_R006_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268571/GSM268571_1557311034_R006_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268571/GSM268571_1557311034_R006_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268571/GSM268571_1557311034_R006_C004_Red.xml.gz","526"
"GSM268572","Patient 324 Core Set (custom panel)","GSM268572","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 10.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 6.24229979466119","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-324","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268572/GSM268572_1557311034_R006_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268572/GSM268572_1557311034_R006_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268572/GSM268572_1557311034_R006_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268572/GSM268572_1557311034_R006_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268572/GSM268572_1557311034_R006_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268572/GSM268572_1557311034_R006_C005_Red.xml.gz","526"
"GSM268573","Patient 332 Core Set (custom panel)","GSM268573","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 26.4","Revised Gleason Score: 7","Stage: TxN+","Ploidy: NA","First Rising PSA (ng/ml): 0.26","Time (yrs) from RRP to first rising PSA: 5.17180013689254","Second Rising PSA (ng/ml): 0.56","Time (yrs) from RRP to second rising PSA: 5.96030116358658","PSA Slope (ng/ml/yr): 0.38046875","Time (yrs) from PSA recurrence to systemic disease: 3.23613963039014","Years of Followup after RRP: 12.3668720054757","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-332","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268573/GSM268573_1557311034_R006_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268573/GSM268573_1557311034_R006_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268573/GSM268573_1557311034_R006_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268573/GSM268573_1557311034_R006_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268573/GSM268573_1557311034_R006_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268573/GSM268573_1557311034_R006_C006_Red.xml.gz","526"
"GSM268574","Patient 341 Core Set (custom panel)","GSM268574","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 19.4","Revised Gleason Score: 9","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.2922655715264","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-341","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268574/GSM268574_1557311034_R006_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268574/GSM268574_1557311034_R006_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268574/GSM268574_1557311034_R006_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268574/GSM268574_1557311034_R006_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268574/GSM268574_1557311034_R006_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268574/GSM268574_1557311034_R006_C007_Red.xml.gz","526"
"GSM268575","Patient 349 Core Set (custom panel)","GSM268575","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 5.7","Revised Gleason Score: 6","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.1204654346338","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-349","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268575/GSM268575_1557311034_R006_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268575/GSM268575_1557311034_R006_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268575/GSM268575_1557311034_R006_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268575/GSM268575_1557311034_R006_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268575/GSM268575_1557311034_R006_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268575/GSM268575_1557311034_R006_C008_Red.xml.gz","526"
"GSM268576","Patient 357 Core Set (custom panel)","GSM268576","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 21.5","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.9780971937029","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-357","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268576/GSM268576_1557311034_R006_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268576/GSM268576_1557311034_R006_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268576/GSM268576_1557311034_R006_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268576/GSM268576_1557311034_R006_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268576/GSM268576_1557311034_R006_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268576/GSM268576_1557311034_R006_C009_Red.xml.gz","526"
"GSM268577","Patient 365 Core Set (custom panel)","GSM268577","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 14.1","Revised Gleason Score: 8","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 19.5","Time (yrs) from RRP to first rising PSA: 0.479123887748118","Second Rising PSA (ng/ml): 21.2","Time (yrs) from RRP to second rising PSA: 0.48186173853525","PSA Slope (ng/ml/yr): 620.925","Time (yrs) from PSA recurrence to systemic disease: 0.317590691307324","Years of Followup after RRP: 3.06639288158795","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-365","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268577/GSM268577_1557311034_R006_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268577/GSM268577_1557311034_R006_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268577/GSM268577_1557311034_R006_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268577/GSM268577_1557311034_R006_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268577/GSM268577_1557311034_R006_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268577/GSM268577_1557311034_R006_C010_Red.xml.gz","526"
"GSM268578","Patient 372 Core Set (custom panel)","GSM268578","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: 5.5","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 2.35728952772074","Second Rising PSA (ng/ml): 3","Time (yrs) from RRP to second rising PSA: 5.68651608487337","PSA Slope (ng/ml/yr): 0.810999177631579","Time (yrs) from PSA recurrence to systemic disease: 2.50513347022587","Years of Followup after RRP: 9.5605749486653","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-372","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268578/GSM268578_1557311034_R006_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268578/GSM268578_1557311034_R006_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268578/GSM268578_1557311034_R006_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268578/GSM268578_1557311034_R006_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268578/GSM268578_1557311034_R006_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268578/GSM268578_1557311034_R006_C011_Red.xml.gz","526"
"GSM268579","Patient 292 Core Set (custom panel)","GSM268579","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 4.7","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 4.47091033538672","Second Rising PSA (ng/ml): 0.36","Time (yrs) from RRP to second rising PSA: 4.81314168377823","PSA Slope (ng/ml/yr): 0.40908","Time (yrs) from PSA recurrence to systemic disease: 5.49760438056126","Years of Followup after RRP: 10.3353867214237","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-292","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268579/GSM268579_1557311034_R007_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268579/GSM268579_1557311034_R007_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268579/GSM268579_1557311034_R007_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268579/GSM268579_1557311034_R007_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268579/GSM268579_1557311034_R007_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268579/GSM268579_1557311034_R007_C001_Red.xml.gz","526"
"GSM268580","Patient 300 Core Set (custom panel)","GSM268580","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 21.3","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.37","Time (yrs) from RRP to first rising PSA: 4.88432580424367","Second Rising PSA (ng/ml): 1.3","Time (yrs) from RRP to second rising PSA: 5.90006844626968","PSA Slope (ng/ml/yr): 0.915586253369272","Time (yrs) from PSA recurrence to systemic disease: 1.05133470225873","Years of Followup after RRP: 7.93702943189596","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-300","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268580/GSM268580_1557311034_R007_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268580/GSM268580_1557311034_R007_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268580/GSM268580_1557311034_R007_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268580/GSM268580_1557311034_R007_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268580/GSM268580_1557311034_R007_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268580/GSM268580_1557311034_R007_C002_Red.xml.gz","526"
"GSM268581","Patient 308 Core Set (custom panel)","GSM268581","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 9.7","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 1.02","Time (yrs) from RRP to first rising PSA: 3.90143737166324","Second Rising PSA (ng/ml): 3.7","Time (yrs) from RRP to second rising PSA: 4.65434633812457","PSA Slope (ng/ml/yr): 3.55952727272727","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.7994524298426","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-308","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268581/GSM268581_1557311034_R007_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268581/GSM268581_1557311034_R007_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268581/GSM268581_1557311034_R007_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268581/GSM268581_1557311034_R007_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268581/GSM268581_1557311034_R007_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268581/GSM268581_1557311034_R007_C003_Red.xml.gz","526"
"GSM268582","Patient 317 Core Set (custom panel)","GSM268582","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 5.2","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.26","Time (yrs) from RRP to first rising PSA: 3.40041067761807","Second Rising PSA (ng/ml): 0.35","Time (yrs) from RRP to second rising PSA: 3.8466803559206","PSA Slope (ng/ml/yr): 0.201671779141104","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.93908281998631","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-317","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268582/GSM268582_1557311034_R007_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268582/GSM268582_1557311034_R007_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268582/GSM268582_1557311034_R007_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268582/GSM268582_1557311034_R007_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268582/GSM268582_1557311034_R007_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268582/GSM268582_1557311034_R007_C004_Red.xml.gz","526"
"GSM268583","Patient 325 Core Set (custom panel)","GSM268583","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 39.6","Revised Gleason Score: 9","Stage: TxN+","Ploidy: aneuploid","First Rising PSA (ng/ml): 5.5","Time (yrs) from RRP to first rising PSA: 4.75290896646133","Second Rising PSA (ng/ml): 9.8","Time (yrs) from RRP to second rising PSA: 5.12799452429843","PSA Slope (ng/ml/yr): 11.4640510948905","Time (yrs) from PSA recurrence to systemic disease: 1.8425735797399","Years of Followup after RRP: 7.38945927446954","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-325","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268583/GSM268583_1557311034_R007_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268583/GSM268583_1557311034_R007_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268583/GSM268583_1557311034_R007_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268583/GSM268583_1557311034_R007_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268583/GSM268583_1557311034_R007_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268583/GSM268583_1557311034_R007_C005_Red.xml.gz","526"
"GSM268584","Patient 342 Core Set (custom panel)","GSM268584","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 3.4","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.8008213552361","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-342","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268584/GSM268584_1557311034_R007_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268584/GSM268584_1557311034_R007_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268584/GSM268584_1557311034_R007_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268584/GSM268584_1557311034_R007_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268584/GSM268584_1557311034_R007_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268584/GSM268584_1557311034_R007_C007_Red.xml.gz","526"
"GSM268585","Patient 350 Core Set (custom panel)","GSM268585","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 34","Revised Gleason Score: 9","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.793976728268309","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 1.29500342231348","PSA Slope (ng/ml/yr): 0.798360655737705","Time (yrs) from PSA recurrence to systemic disease: 3.65503080082136","Years of Followup after RRP: 9.28952772073922","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-350","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268585/GSM268585_1557311034_R007_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268585/GSM268585_1557311034_R007_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268585/GSM268585_1557311034_R007_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268585/GSM268585_1557311034_R007_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268585/GSM268585_1557311034_R007_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268585/GSM268585_1557311034_R007_C008_Red.xml.gz","526"
"GSM268586","Patient 358 Core Set (custom panel)","GSM268586","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 6.4","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.922655715263518","Second Rising PSA (ng/ml): 7.6","Time (yrs) from RRP to second rising PSA: 0.966461327857632","PSA Slope (ng/ml/yr): 168.928125","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.90622861054073","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-358","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268586/GSM268586_1557311034_R007_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268586/GSM268586_1557311034_R007_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268586/GSM268586_1557311034_R007_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268586/GSM268586_1557311034_R007_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268586/GSM268586_1557311034_R007_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268586/GSM268586_1557311034_R007_C009_Red.xml.gz","526"
"GSM268587","Patient 366 Core Set (custom panel)","GSM268587","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 54","PSA (ng/ml) at RRP: 7.9","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 2.17385352498289","Second Rising PSA (ng/ml): 0.8","Time (yrs) from RRP to second rising PSA: 3.17590691307324","PSA Slope (ng/ml/yr): 0.299385245901639","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.2251882272416","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-366","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268587/GSM268587_1557311034_R007_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268587/GSM268587_1557311034_R007_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268587/GSM268587_1557311034_R007_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268587/GSM268587_1557311034_R007_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268587/GSM268587_1557311034_R007_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268587/GSM268587_1557311034_R007_C010_Red.xml.gz","526"
"GSM268588","Patient 378 Core Set (custom panel)","GSM268588","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 50","PSA (ng/ml) at RRP: 36","Revised Gleason Score: 9","Stage: TxN+","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 1.30595482546201","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 1.31964407939767","PSA Slope (ng/ml/yr): 14.61","Time (yrs) from PSA recurrence to systemic disease: 1.00205338809035","Years of Followup after RRP: 4.01095140314853","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-378","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268588/GSM268588_1557311034_R007_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268588/GSM268588_1557311034_R007_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268588/GSM268588_1557311034_R007_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268588/GSM268588_1557311034_R007_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268588/GSM268588_1557311034_R007_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268588/GSM268588_1557311034_R007_C012_Red.xml.gz","526"
"GSM268589","Patient 293 Core Set (custom panel)","GSM268589","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 6.4","Revised Gleason Score: 8","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 1.71937029431896","Second Rising PSA (ng/ml): 0.63","Time (yrs) from RRP to second rising PSA: 2.08898015058179","PSA Slope (ng/ml/yr): 0.351722222222222","Time (yrs) from PSA recurrence to systemic disease: 2.49965776865161","Years of Followup after RRP: 10.009582477755","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-293","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268589/GSM268589_1557311034_R008_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268589/GSM268589_1557311034_R008_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268589/GSM268589_1557311034_R008_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268589/GSM268589_1557311034_R008_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268589/GSM268589_1557311034_R008_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268589/GSM268589_1557311034_R008_C001_Red.xml.gz","526"
"GSM268590","Patient 318 Core Set (custom panel)","GSM268590","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 8.6","Revised Gleason Score: 7","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 0.23","Time (yrs) from RRP to first rising PSA: 2.8911704312115","Second Rising PSA (ng/ml): 0.46","Time (yrs) from RRP to second rising PSA: 3.89869952087611","PSA Slope (ng/ml/yr): 0.22828125","Time (yrs) from PSA recurrence to systemic disease: 3.92881587953457","Years of Followup after RRP: 9.00479123887748","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-318","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268590/GSM268590_1557311034_R008_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268590/GSM268590_1557311034_R008_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268590/GSM268590_1557311034_R008_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268590/GSM268590_1557311034_R008_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268590/GSM268590_1557311034_R008_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268590/GSM268590_1557311034_R008_C004_Red.xml.gz","526"
"GSM268591","Patient 326 Core Set (custom panel)","GSM268591","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 4.3","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.5373032169747","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-326","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268591/GSM268591_1557311034_R008_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268591/GSM268591_1557311034_R008_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268591/GSM268591_1557311034_R008_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268591/GSM268591_1557311034_R008_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268591/GSM268591_1557311034_R008_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268591/GSM268591_1557311034_R008_C005_Red.xml.gz","526"
"GSM268592","Patient 334 Core Set (custom panel)","GSM268592","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 1.6","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.35","Time (yrs) from RRP to first rising PSA: 9.1088295687885","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 9.71937029431896","PSA Slope (ng/ml/yr): 0.245683856502242","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.1232032854209","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-334","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268592/GSM268592_1557311034_R008_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268592/GSM268592_1557311034_R008_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268592/GSM268592_1557311034_R008_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268592/GSM268592_1557311034_R008_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268592/GSM268592_1557311034_R008_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268592/GSM268592_1557311034_R008_C006_Red.xml.gz","526"
"GSM268593","Patient 343 Core Set (custom panel)","GSM268593","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 6.5","Revised Gleason Score: 6","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 4.41067761806982","Second Rising PSA (ng/ml): 0.9","Time (yrs) from RRP to second rising PSA: 6.40109514031485","PSA Slope (ng/ml/yr): 0.200962861072902","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.5420944558522","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-343","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268593/GSM268593_1557311034_R008_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268593/GSM268593_1557311034_R008_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268593/GSM268593_1557311034_R008_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268593/GSM268593_1557311034_R008_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268593/GSM268593_1557311034_R008_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268593/GSM268593_1557311034_R008_C007_Red.xml.gz","526"
"GSM268594","Patient 359 Core Set (custom panel)","GSM268594","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 3.1","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 3.81930184804928","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 4.90349075975359","PSA Slope (ng/ml/yr): 0.0922348484848485","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.2655715263518","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-359","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268594/GSM268594_1557311034_R008_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268594/GSM268594_1557311034_R008_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268594/GSM268594_1557311034_R008_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268594/GSM268594_1557311034_R008_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268594/GSM268594_1557311034_R008_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268594/GSM268594_1557311034_R008_C009_Red.xml.gz","526"
"GSM268595","Patient 373 Core Set (custom panel)","GSM268595","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 27.9","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 1.42368240930869","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 1.73032169746749","PSA Slope (ng/ml/yr): 0.326116071428572","Time (yrs) from PSA recurrence to systemic disease: 9.22108145106092","Years of Followup after RRP: 12.1122518822724","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-373","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268595/GSM268595_1557311034_R008_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268595/GSM268595_1557311034_R008_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268595/GSM268595_1557311034_R008_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268595/GSM268595_1557311034_R008_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268595/GSM268595_1557311034_R008_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268595/GSM268595_1557311034_R008_C011_Red.xml.gz","526"
"GSM268596","Patient 380 Core Set (custom panel)","GSM268596","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 3.80561259411362","Second Rising PSA (ng/ml): 3.6","Time (yrs) from RRP to second rising PSA: 5.18001368925394","PSA Slope (ng/ml/yr): 2.32828685258964","Time (yrs) from PSA recurrence to systemic disease: 1.34976043805613","Years of Followup after RRP: 16.4490075290897","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-380","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268596/GSM268596_1559931034_R001_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268596/GSM268596_1559931034_R001_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268596/GSM268596_1559931034_R001_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268596/GSM268596_1559931034_R001_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268596/GSM268596_1559931034_R001_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268596/GSM268596_1559931034_R001_C002_Red.xml.gz","526"
"GSM268597","Patient 387 Core Set (custom panel)","GSM268597","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 7.8","Revised Gleason Score: 8","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.2340862422998","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-387","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268597/GSM268597_1559931034_R001_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268597/GSM268597_1559931034_R001_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268597/GSM268597_1559931034_R001_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268597/GSM268597_1559931034_R001_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268597/GSM268597_1559931034_R001_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268597/GSM268597_1559931034_R001_C003_Red.xml.gz","526"
"GSM268598","Patient 395 Core Set (custom panel)","GSM268598","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 6.6","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 6.35728952772074","Second Rising PSA (ng/ml): 2.6","Time (yrs) from RRP to second rising PSA: 6.85557837097878","PSA Slope (ng/ml/yr): 4.41510989010989","Time (yrs) from PSA recurrence to systemic disease: 4.92813141683778","Years of Followup after RRP: 13.5003422313484","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-395","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268598/GSM268598_1559931034_R001_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268598/GSM268598_1559931034_R001_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268598/GSM268598_1559931034_R001_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268598/GSM268598_1559931034_R001_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268598/GSM268598_1559931034_R001_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268598/GSM268598_1559931034_R001_C004_Red.xml.gz","526"
"GSM268599","Patient 403 Core Set (custom panel)","GSM268599","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 12.8","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 4.04380561259411","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 4.5968514715948","PSA Slope (ng/ml/yr): 0.180816831683168","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.1416837782341","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-403","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268599/GSM268599_1559931034_R001_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268599/GSM268599_1559931034_R001_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268599/GSM268599_1559931034_R001_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268599/GSM268599_1559931034_R001_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268599/GSM268599_1559931034_R001_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268599/GSM268599_1559931034_R001_C005_Red.xml.gz","526"
"GSM268600","Patient 411 Core Set (custom panel)","GSM268600","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 17.3","Revised Gleason Score: 8","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.31211498973306","Second Rising PSA (ng/ml): 5.2","Time (yrs) from RRP to second rising PSA: 3.39493497604381","PSA Slope (ng/ml/yr): 1.62189165186501","Time (yrs) from PSA recurrence to systemic disease: 1.83709787816564","Years of Followup after RRP: 7.6933607118412","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-411","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268600/GSM268600_1559931034_R001_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268600/GSM268600_1559931034_R001_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268600/GSM268600_1559931034_R001_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268600/GSM268600_1559931034_R001_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268600/GSM268600_1559931034_R001_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268600/GSM268600_1559931034_R001_C006_Red.xml.gz","526"
"GSM268601","Patient 419 Core Set (custom panel)","GSM268601","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 5.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.97809719370294","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-419","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268601/GSM268601_1559931034_R001_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268601/GSM268601_1559931034_R001_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268601/GSM268601_1559931034_R001_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268601/GSM268601_1559931034_R001_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268601/GSM268601_1559931034_R001_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268601/GSM268601_1559931034_R001_C007_Red.xml.gz","526"
"GSM268602","Patient 427 Core Set (custom panel)","GSM268602","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 5.3","Revised Gleason Score: 8","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.824093086926763","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 1.98220396988364","PSA Slope (ng/ml/yr): 0.172695035460993","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.0780287474333","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-427","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268602/GSM268602_1559931034_R001_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268602/GSM268602_1559931034_R001_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268602/GSM268602_1559931034_R001_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268602/GSM268602_1559931034_R001_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268602/GSM268602_1559931034_R001_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268602/GSM268602_1559931034_R001_C008_Red.xml.gz","526"
"GSM268603","Patient 437 Core Set (custom panel)","GSM268603","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 10.4","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.37","Time (yrs) from RRP to first rising PSA: 7.11841204654346","Second Rising PSA (ng/ml): 0.52","Time (yrs) from RRP to second rising PSA: 8.42436687200547","PSA Slope (ng/ml/yr): 0.114858490566038","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.4346338124572","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-437","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268603/GSM268603_1559931034_R001_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268603/GSM268603_1559931034_R001_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268603/GSM268603_1559931034_R001_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268603/GSM268603_1559931034_R001_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268603/GSM268603_1559931034_R001_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268603/GSM268603_1559931034_R001_C009_Red.xml.gz","526"
"GSM268604","Patient 445 Core Set (custom panel)","GSM268604","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 40.9","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 2.00136892539357","Second Rising PSA (ng/ml): 0.37","Time (yrs) from RRP to second rising PSA: 2.17932922655715","PSA Slope (ng/ml/yr): 0.842884615384615","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-445","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268604/GSM268604_1559931034_R001_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268604/GSM268604_1559931034_R001_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268604/GSM268604_1559931034_R001_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268604/GSM268604_1559931034_R001_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268604/GSM268604_1559931034_R001_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268604/GSM268604_1559931034_R001_C010_Red.xml.gz","526"
"GSM268605","Patient 453 Core Set (custom panel)","GSM268605","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 2.29979466119096","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 2.55167693360712","PSA Slope (ng/ml/yr): 0.397010869565217","Time (yrs) from PSA recurrence to systemic disease: 2.45311430527036","Years of Followup after RRP: 12.8733744010951","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-453","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268605/GSM268605_1559931034_R001_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268605/GSM268605_1559931034_R001_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268605/GSM268605_1559931034_R001_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268605/GSM268605_1559931034_R001_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268605/GSM268605_1559931034_R001_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268605/GSM268605_1559931034_R001_C011_Red.xml.gz","526"
"GSM268606","Patient 381 Core Set (custom panel)","GSM268606","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 75","PSA (ng/ml) at RRP: 7.4","Revised Gleason Score: 6","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.4715947980835","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-381","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268606/GSM268606_1559931034_R002_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268606/GSM268606_1559931034_R002_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268606/GSM268606_1559931034_R002_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268606/GSM268606_1559931034_R002_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268606/GSM268606_1559931034_R002_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268606/GSM268606_1559931034_R002_C002_Red.xml.gz","526"
"GSM268607","Patient 388 Core Set (custom panel)","GSM268607","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 13.2","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.32717316906229","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 2.60369609856263","PSA Slope (ng/ml/yr): 1.44653465346535","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.337440109514","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-388","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268607/GSM268607_1559931034_R002_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268607/GSM268607_1559931034_R002_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268607/GSM268607_1559931034_R002_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268607/GSM268607_1559931034_R002_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268607/GSM268607_1559931034_R002_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268607/GSM268607_1559931034_R002_C003_Red.xml.gz","526"
"GSM268608","Patient 396 Core Set (custom panel)","GSM268608","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 7.4","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.939082819986311","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 1.09787816563997","PSA Slope (ng/ml/yr): 1.88922413793103","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.9863107460643","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-396","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268608/GSM268608_1559931034_R002_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268608/GSM268608_1559931034_R002_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268608/GSM268608_1559931034_R002_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268608/GSM268608_1559931034_R002_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268608/GSM268608_1559931034_R002_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268608/GSM268608_1559931034_R002_C004_Red.xml.gz","526"
"GSM268609","Patient 404 Core Set (custom panel)","GSM268609","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 16.5","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.7310061601643","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-404","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268609/GSM268609_1559931034_R002_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268609/GSM268609_1559931034_R002_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268609/GSM268609_1559931034_R002_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268609/GSM268609_1559931034_R002_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268609/GSM268609_1559931034_R002_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268609/GSM268609_1559931034_R002_C005_Red.xml.gz","526"
"GSM268610","Patient 412 Core Set (custom panel)","GSM268610","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 14.9","Revised Gleason Score: 9","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.09924709103354","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-412","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268610/GSM268610_1559931034_R002_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268610/GSM268610_1559931034_R002_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268610/GSM268610_1559931034_R002_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268610/GSM268610_1559931034_R002_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268610/GSM268610_1559931034_R002_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268610/GSM268610_1559931034_R002_C006_Red.xml.gz","526"
"GSM268611","Patient 420 Core Set (custom panel)","GSM268611","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 14.3","Revised Gleason Score: 9","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.974674880219028","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 1.37713894592745","PSA Slope (ng/ml/yr): 0.496938775510204","Time (yrs) from PSA recurrence to systemic disease: 1.79329226557153","Years of Followup after RRP: 4.16427104722793","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-420","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268611/GSM268611_1559931034_R002_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268611/GSM268611_1559931034_R002_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268611/GSM268611_1559931034_R002_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268611/GSM268611_1559931034_R002_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268611/GSM268611_1559931034_R002_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268611/GSM268611_1559931034_R002_C007_Red.xml.gz","526"
"GSM268612","Patient 438 Core Set (custom panel)","GSM268612","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 6.2","Revised Gleason Score: 10","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): 1","Time (yrs) from RRP to first rising PSA: 1.70294318959617","Second Rising PSA (ng/ml): 1.1","Time (yrs) from RRP to second rising PSA: 1.82888432580424","PSA Slope (ng/ml/yr): 0.794021739130436","Time (yrs) from PSA recurrence to systemic disease: 2.94045174537988","Years of Followup after RRP: 7.4715947980835","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-438","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268612/GSM268612_1559931034_R002_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268612/GSM268612_1559931034_R002_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268612/GSM268612_1559931034_R002_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268612/GSM268612_1559931034_R002_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268612/GSM268612_1559931034_R002_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268612/GSM268612_1559931034_R002_C009_Red.xml.gz","526"
"GSM268613","Patient 446 Core Set (custom panel)","GSM268613","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 11.3","Revised Gleason Score: 8","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 4.33949349760438","Second Rising PSA (ng/ml): 0.43","Time (yrs) from RRP to second rising PSA: 5.01574264202601","PSA Slope (ng/ml/yr): 0.340111336032389","Time (yrs) from PSA recurrence to systemic disease: 3.25256673511294","Years of Followup after RRP: 12.8186173853525","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-446","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268613/GSM268613_1559931034_R002_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268613/GSM268613_1559931034_R002_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268613/GSM268613_1559931034_R002_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268613/GSM268613_1559931034_R002_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268613/GSM268613_1559931034_R002_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268613/GSM268613_1559931034_R002_C010_Red.xml.gz","526"
"GSM268614","Patient 460 Core Set (custom panel)","GSM268614","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 4.1","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 4.26830937713895","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 5.56878850102669","PSA Slope (ng/ml/yr): 0.0768947368421052","Time (yrs) from PSA recurrence to systemic disease: 4.17248459958932","Years of Followup after RRP: 11.7043121149897","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-460","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268614/GSM268614_1559931034_R002_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268614/GSM268614_1559931034_R002_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268614/GSM268614_1559931034_R002_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268614/GSM268614_1559931034_R002_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268614/GSM268614_1559931034_R002_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268614/GSM268614_1559931034_R002_C012_Red.xml.gz","526"
"GSM268615","Patient 382 Core Set (custom panel)","GSM268615","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 8.7","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.69130732375086","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 3.2662559890486","PSA Slope (ng/ml/yr): 0.173928571428571","Time (yrs) from PSA recurrence to systemic disease: 2.75427789185489","Years of Followup after RRP: 13.7631759069131","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-382","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268615/GSM268615_1559931034_R003_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268615/GSM268615_1559931034_R003_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268615/GSM268615_1559931034_R003_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268615/GSM268615_1559931034_R003_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268615/GSM268615_1559931034_R003_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268615/GSM268615_1559931034_R003_C002_Red.xml.gz","526"
"GSM268616","Patient 389 Core Set (custom panel)","GSM268616","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 16.8","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.7577002053388","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-389","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268616/GSM268616_1559931034_R003_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268616/GSM268616_1559931034_R003_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268616/GSM268616_1559931034_R003_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268616/GSM268616_1559931034_R003_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268616/GSM268616_1559931034_R003_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268616/GSM268616_1559931034_R003_C003_Red.xml.gz","526"
"GSM268617","Patient 397 Core Set (custom panel)","GSM268617","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 9.6","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.42778918548939","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-397","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268617/GSM268617_1559931034_R003_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268617/GSM268617_1559931034_R003_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268617/GSM268617_1559931034_R003_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268617/GSM268617_1559931034_R003_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268617/GSM268617_1559931034_R003_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268617/GSM268617_1559931034_R003_C004_Red.xml.gz","526"
"GSM268618","Patient 405 Core Set (custom panel)","GSM268618","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 55","PSA (ng/ml) at RRP: 6.8","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.8466803559206","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-405","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268618/GSM268618_1559931034_R003_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268618/GSM268618_1559931034_R003_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268618/GSM268618_1559931034_R003_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268618/GSM268618_1559931034_R003_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268618/GSM268618_1559931034_R003_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268618/GSM268618_1559931034_R003_C005_Red.xml.gz","526"
"GSM268619","Patient 413 Core Set (custom panel)","GSM268619","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 7","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.0766598220397","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-413","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268619/GSM268619_1559931034_R003_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268619/GSM268619_1559931034_R003_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268619/GSM268619_1559931034_R003_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268619/GSM268619_1559931034_R003_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268619/GSM268619_1559931034_R003_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268619/GSM268619_1559931034_R003_C006_Red.xml.gz","526"
"GSM268620","Patient 421 Core Set (custom panel)","GSM268620","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 9.94113620807666","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 10.9158110882957","PSA Slope (ng/ml/yr): 0.102598314606742","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 17.6892539356605","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-421","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268620/GSM268620_1559931034_R003_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268620/GSM268620_1559931034_R003_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268620/GSM268620_1559931034_R003_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268620/GSM268620_1559931034_R003_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268620/GSM268620_1559931034_R003_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268620/GSM268620_1559931034_R003_C007_Red.xml.gz","526"
"GSM268621","Patient 439 Core Set (custom panel)","GSM268621","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 76","PSA (ng/ml) at RRP: 21","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.45242984257358","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-439","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268621/GSM268621_1559931034_R003_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268621/GSM268621_1559931034_R003_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268621/GSM268621_1559931034_R003_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268621/GSM268621_1559931034_R003_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268621/GSM268621_1559931034_R003_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268621/GSM268621_1559931034_R003_C009_Red.xml.gz","526"
"GSM268622","Patient 447 Core Set (custom panel)","GSM268622","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 7.9","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 0.15605749486653","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 0.320328542094456","PSA Slope (ng/ml/yr): 0.60875","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.04585900068446","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-447","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268622/GSM268622_1559931034_R003_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268622/GSM268622_1559931034_R003_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268622/GSM268622_1559931034_R003_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268622/GSM268622_1559931034_R003_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268622/GSM268622_1559931034_R003_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268622/GSM268622_1559931034_R003_C010_Red.xml.gz","526"
"GSM268623","Patient 454 Core Set (custom panel)","GSM268623","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 17.3","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 4.33401779603012","Second Rising PSA (ng/ml): 11.84","Time (yrs) from RRP to second rising PSA: 5.87816563997262","PSA Slope (ng/ml/yr): 7.53813829787234","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.0958247775496","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-454","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268623/GSM268623_1559931034_R003_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268623/GSM268623_1559931034_R003_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268623/GSM268623_1559931034_R003_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268623/GSM268623_1559931034_R003_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268623/GSM268623_1559931034_R003_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268623/GSM268623_1559931034_R003_C011_Red.xml.gz","526"
"GSM268624","Patient 461 Core Set (custom panel)","GSM268624","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 7.9","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.249144421629021","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 0.347707049965777","PSA Slope (ng/ml/yr): 2.02916666666667","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.30937713894593","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-461","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268624/GSM268624_1559931034_R003_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268624/GSM268624_1559931034_R003_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268624/GSM268624_1559931034_R003_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268624/GSM268624_1559931034_R003_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268624/GSM268624_1559931034_R003_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268624/GSM268624_1559931034_R003_C012_Red.xml.gz","526"
"GSM268625","Patient 040 Core Set (custom panel)","GSM268625","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: 7.5","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.3675564681725","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-040","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268625/GSM268625_1559931034_R004_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268625/GSM268625_1559931034_R004_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268625/GSM268625_1559931034_R004_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268625/GSM268625_1559931034_R004_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268625/GSM268625_1559931034_R004_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268625/GSM268625_1559931034_R004_C001_Red.xml.gz","526"
"GSM268626","Patient 390 Core Set (custom panel)","GSM268626","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: 24.2","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.632443531827515","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 0.884325804243669","PSA Slope (ng/ml/yr): 0.397010869565217","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.0239561943874","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-390","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268626/GSM268626_1559931034_R004_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268626/GSM268626_1559931034_R004_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268626/GSM268626_1559931034_R004_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268626/GSM268626_1559931034_R004_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268626/GSM268626_1559931034_R004_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268626/GSM268626_1559931034_R004_C003_Red.xml.gz","526"
"GSM268627","Patient 398 Core Set (custom panel)","GSM268627","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 7.5","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.76","Time (yrs) from RRP to first rising PSA: 7.66050650239562","Second Rising PSA (ng/ml): 1.3","Time (yrs) from RRP to second rising PSA: 8.87337440109514","PSA Slope (ng/ml/yr): 0.445225733634312","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.8364134154689","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-398","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268627/GSM268627_1559931034_R004_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268627/GSM268627_1559931034_R004_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268627/GSM268627_1559931034_R004_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268627/GSM268627_1559931034_R004_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268627/GSM268627_1559931034_R004_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268627/GSM268627_1559931034_R004_C004_Red.xml.gz","526"
"GSM268628","Patient 406 Core Set (custom panel)","GSM268628","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.32785763175907","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 1.81793292265572","PSA Slope (ng/ml/yr): 0.408100558659218","Time (yrs) from PSA recurrence to systemic disease: 2.03422313483915","Years of Followup after RRP: 15.8740588637919","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-406","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268628/GSM268628_1559931034_R004_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268628/GSM268628_1559931034_R004_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268628/GSM268628_1559931034_R004_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268628/GSM268628_1559931034_R004_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268628/GSM268628_1559931034_R004_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268628/GSM268628_1559931034_R004_C005_Red.xml.gz","526"
"GSM268629","Patient 414 Core Set (custom panel)","GSM268629","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 5.1","Revised Gleason Score: 7","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 4.60506502395619","Second Rising PSA (ng/ml): 0.35","Time (yrs) from RRP to second rising PSA: 5.02669404517454","PSA Slope (ng/ml/yr): 0.355762987012987","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.06776180698152","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-414","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268629/GSM268629_1559931034_R004_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268629/GSM268629_1559931034_R004_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268629/GSM268629_1559931034_R004_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268629/GSM268629_1559931034_R004_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268629/GSM268629_1559931034_R004_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268629/GSM268629_1559931034_R004_C006_Red.xml.gz","526"
"GSM268630","Patient 422 Core Set (custom panel)","GSM268630","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 5.8","Revised Gleason Score: 6","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 3.39767282683094","Second Rising PSA (ng/ml): 1.3","Time (yrs) from RRP to second rising PSA: 4.32580424366872","PSA Slope (ng/ml/yr): 0.646460176991151","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.4483230663929","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-422","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268630/GSM268630_1559931034_R004_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268630/GSM268630_1559931034_R004_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268630/GSM268630_1559931034_R004_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268630/GSM268630_1559931034_R004_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268630/GSM268630_1559931034_R004_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268630/GSM268630_1559931034_R004_C007_Red.xml.gz","526"
"GSM268631","Patient 430 Core Set (custom panel)","GSM268631","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 3.9","Revised Gleason Score: 6","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 17.2402464065708","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-430","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268631/GSM268631_1559931034_R004_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268631/GSM268631_1559931034_R004_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268631/GSM268631_1559931034_R004_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268631/GSM268631_1559931034_R004_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268631/GSM268631_1559931034_R004_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268631/GSM268631_1559931034_R004_C008_Red.xml.gz","526"
"GSM268632","Patient 448 Core Set (custom panel)","GSM268632","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 17.9","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.2012320328542","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-448","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268632/GSM268632_1559931034_R004_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268632/GSM268632_1559931034_R004_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268632/GSM268632_1559931034_R004_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268632/GSM268632_1559931034_R004_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268632/GSM268632_1559931034_R004_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268632/GSM268632_1559931034_R004_C010_Red.xml.gz","526"
"GSM268633","Patient 455 Core Set (custom panel)","GSM268633","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 7.1","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.2395619438741","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-455","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268633/GSM268633_1559931034_R004_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268633/GSM268633_1559931034_R004_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268633/GSM268633_1559931034_R004_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268633/GSM268633_1559931034_R004_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268633/GSM268633_1559931034_R004_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268633/GSM268633_1559931034_R004_C011_Red.xml.gz","526"
"GSM268634","Patient 462 Core Set (custom panel)","GSM268634","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 5.8","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 1","Time (yrs) from RRP to first rising PSA: 3.27173169062286","Second Rising PSA (ng/ml): 2.5","Time (yrs) from RRP to second rising PSA: 3.83299110198494","PSA Slope (ng/ml/yr): 2.67256097560976","Time (yrs) from PSA recurrence to systemic disease: 3.08281998631075","Years of Followup after RRP: 10.7378507871321","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-462","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268634/GSM268634_1559931034_R004_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268634/GSM268634_1559931034_R004_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268634/GSM268634_1559931034_R004_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268634/GSM268634_1559931034_R004_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268634/GSM268634_1559931034_R004_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268634/GSM268634_1559931034_R004_C012_Red.xml.gz","526"
"GSM268635","Patient 060 Core Set (custom panel)","GSM268635","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 54","PSA (ng/ml) at RRP: 9.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.8062970568104","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-060","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268635/GSM268635_1559931034_R005_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268635/GSM268635_1559931034_R005_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268635/GSM268635_1559931034_R005_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268635/GSM268635_1559931034_R005_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268635/GSM268635_1559931034_R005_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268635/GSM268635_1559931034_R005_C001_Red.xml.gz","526"
"GSM268636","Patient 383 Core Set (custom panel)","GSM268636","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 52","PSA (ng/ml) at RRP: 9.3","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 5.65639972621492","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 6.77070499657769","PSA Slope (ng/ml/yr): 0.0897420147420148","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.8658453114305","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-383","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268636/GSM268636_1559931034_R005_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268636/GSM268636_1559931034_R005_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268636/GSM268636_1559931034_R005_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268636/GSM268636_1559931034_R005_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268636/GSM268636_1559931034_R005_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268636/GSM268636_1559931034_R005_C002_Red.xml.gz","526"
"GSM268637","Patient 399 Core Set (custom panel)","GSM268637","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: 5.6","Revised Gleason Score: 6","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 0.618754277891855","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 0.665297741273101","PSA Slope (ng/ml/yr): 2.14852941176471","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.9678302532512","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-399","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268637/GSM268637_1559931034_R005_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268637/GSM268637_1559931034_R005_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268637/GSM268637_1559931034_R005_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268637/GSM268637_1559931034_R005_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268637/GSM268637_1559931034_R005_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268637/GSM268637_1559931034_R005_C004_Red.xml.gz","526"
"GSM268638","Patient 407 Core Set (custom panel)","GSM268638","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 1.9","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to first rising PSA: 6.69952087611225","Second Rising PSA (ng/ml): 7.2","Time (yrs) from RRP to second rising PSA: 8.4517453798768","PSA Slope (ng/ml/yr): 3.766640625","Time (yrs) from PSA recurrence to systemic disease: 0.16974674880219","Years of Followup after RRP: 10.1409993155373","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-407","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268638/GSM268638_1559931034_R005_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268638/GSM268638_1559931034_R005_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268638/GSM268638_1559931034_R005_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268638/GSM268638_1559931034_R005_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268638/GSM268638_1559931034_R005_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268638/GSM268638_1559931034_R005_C005_Red.xml.gz","526"
"GSM268639","Patient 415 Core Set (custom panel)","GSM268639","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 4.8","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.824093086926763","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 1.25941136208077","PSA Slope (ng/ml/yr): 0.229716981132075","Time (yrs) from PSA recurrence to systemic disease: 7.63039014373717","Years of Followup after RRP: 12.3832991101985","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-415","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268639/GSM268639_1559931034_R005_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268639/GSM268639_1559931034_R005_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268639/GSM268639_1559931034_R005_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268639/GSM268639_1559931034_R005_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268639/GSM268639_1559931034_R005_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268639/GSM268639_1559931034_R005_C006_Red.xml.gz","526"
"GSM268640","Patient 423 Core Set (custom panel)","GSM268640","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 6.8","Revised Gleason Score: 5","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.5434633812457","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-423","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268640/GSM268640_1559931034_R005_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268640/GSM268640_1559931034_R005_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268640/GSM268640_1559931034_R005_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268640/GSM268640_1559931034_R005_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268640/GSM268640_1559931034_R005_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268640/GSM268640_1559931034_R005_C007_Red.xml.gz","526"
"GSM268641","Patient 432 Core Set (custom panel)","GSM268641","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 48.1","Revised Gleason Score: 9","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 2.4","Time (yrs) from RRP to first rising PSA: 0.331279945242984","Second Rising PSA (ng/ml): 3.6","Time (yrs) from RRP to second rising PSA: 0.815879534565366","PSA Slope (ng/ml/yr): 2.47627118644068","Time (yrs) from PSA recurrence to systemic disease: 3.99452429842574","Years of Followup after RRP: 11.2169746748802","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-432","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268641/GSM268641_1559931034_R005_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268641/GSM268641_1559931034_R005_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268641/GSM268641_1559931034_R005_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268641/GSM268641_1559931034_R005_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268641/GSM268641_1559931034_R005_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268641/GSM268641_1559931034_R005_C008_Red.xml.gz","526"
"GSM268642","Patient 441 Core Set (custom panel)","GSM268642","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 17.2","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.42915811088296","Second Rising PSA (ng/ml): 0.49","Time (yrs) from RRP to second rising PSA: 2.072553045859","PSA Slope (ng/ml/yr): 0.450734042553191","Time (yrs) from PSA recurrence to systemic disease: 3.33196440793977","Years of Followup after RRP: 5.77960301163587","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-441","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268642/GSM268642_1559931034_R005_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268642/GSM268642_1559931034_R005_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268642/GSM268642_1559931034_R005_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268642/GSM268642_1559931034_R005_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268642/GSM268642_1559931034_R005_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268642/GSM268642_1559931034_R005_C009_Red.xml.gz","526"
"GSM268643","Patient 449 Core Set (custom panel)","GSM268643","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 8.6","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 1.97946611909651","Second Rising PSA (ng/ml): 1.2","Time (yrs) from RRP to second rising PSA: 2.27241615331964","PSA Slope (ng/ml/yr): 2.73084112149533","Time (yrs) from PSA recurrence to systemic disease: 0.197125256673511","Years of Followup after RRP: 11.1238877481177","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-449","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268643/GSM268643_1559931034_R005_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268643/GSM268643_1559931034_R005_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268643/GSM268643_1559931034_R005_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268643/GSM268643_1559931034_R005_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268643/GSM268643_1559931034_R005_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268643/GSM268643_1559931034_R005_C010_Red.xml.gz","526"
"GSM268644","Patient 456 Core Set (custom panel)","GSM268644","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 2","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 3.16221765913758","Second Rising PSA (ng/ml): 0.9","Time (yrs) from RRP to second rising PSA: 3.39219712525667","PSA Slope (ng/ml/yr): 0.869642857142857","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.72347707049966","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-456","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268644/GSM268644_1559931034_R005_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268644/GSM268644_1559931034_R005_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268644/GSM268644_1559931034_R005_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268644/GSM268644_1559931034_R005_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268644/GSM268644_1559931034_R005_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268644/GSM268644_1559931034_R005_C011_Red.xml.gz","526"
"GSM268645","Patient 463 Core Set (custom panel)","GSM268645","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 12.7","Revised Gleason Score: 5","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.5023956194387","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-463","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268645/GSM268645_1559931034_R005_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268645/GSM268645_1559931034_R005_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268645/GSM268645_1559931034_R005_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268645/GSM268645_1559931034_R005_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268645/GSM268645_1559931034_R005_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268645/GSM268645_1559931034_R005_C012_Red.xml.gz","526"
"GSM268646","Patient 384 Core Set (custom panel)","GSM268646","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 51","PSA (ng/ml) at RRP: 11.9","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 1.29","Time (yrs) from RRP to first rising PSA: 2.01505817932923","Second Rising PSA (ng/ml): 1.4","Time (yrs) from RRP to second rising PSA: 2.5242984257358","PSA Slope (ng/ml/yr): 0.216008064516129","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.60164271047228","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-384","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268646/GSM268646_1559931034_R006_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268646/GSM268646_1559931034_R006_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268646/GSM268646_1559931034_R006_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268646/GSM268646_1559931034_R006_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268646/GSM268646_1559931034_R006_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268646/GSM268646_1559931034_R006_C002_Red.xml.gz","526"
"GSM268647","Patient 392 Core Set (custom panel)","GSM268647","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 4.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.82340862422998","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-392","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268647/GSM268647_1559931034_R006_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268647/GSM268647_1559931034_R006_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268647/GSM268647_1559931034_R006_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268647/GSM268647_1559931034_R006_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268647/GSM268647_1559931034_R006_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268647/GSM268647_1559931034_R006_C003_Red.xml.gz","526"
"GSM268648","Patient 400 Core Set (custom panel)","GSM268648","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 61","PSA (ng/ml) at RRP: 32.7","Revised Gleason Score: 9","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.1245722108145","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-400","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268648/GSM268648_1559931034_R006_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268648/GSM268648_1559931034_R006_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268648/GSM268648_1559931034_R006_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268648/GSM268648_1559931034_R006_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268648/GSM268648_1559931034_R006_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268648/GSM268648_1559931034_R006_C004_Red.xml.gz","526"
"GSM268649","Patient 408 Core Set (custom panel)","GSM268649","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 5.2","Revised Gleason Score: 9","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 2.89664613278576","Second Rising PSA (ng/ml): 1.5","Time (yrs) from RRP to second rising PSA: 4.53114305270363","PSA Slope (ng/ml/yr): 0.489447236180905","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.0698151950719","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-408","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268649/GSM268649_1559931034_R006_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268649/GSM268649_1559931034_R006_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268649/GSM268649_1559931034_R006_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268649/GSM268649_1559931034_R006_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268649/GSM268649_1559931034_R006_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268649/GSM268649_1559931034_R006_C005_Red.xml.gz","526"
"GSM268650","Patient 416 Core Set (custom panel)","GSM268650","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 10.4","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.6659822039699","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-416","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268650/GSM268650_1559931034_R006_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268650/GSM268650_1559931034_R006_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268650/GSM268650_1559931034_R006_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268650/GSM268650_1559931034_R006_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268650/GSM268650_1559931034_R006_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268650/GSM268650_1559931034_R006_C006_Red.xml.gz","526"
"GSM268651","Patient 424 Core Set (custom panel)","GSM268651","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 7.8","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.75906913073238","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-424","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268651/GSM268651_1559931034_R006_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268651/GSM268651_1559931034_R006_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268651/GSM268651_1559931034_R006_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268651/GSM268651_1559931034_R006_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268651/GSM268651_1559931034_R006_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268651/GSM268651_1559931034_R006_C007_Red.xml.gz","526"
"GSM268652","Patient 433 Core Set (custom panel)","GSM268652","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 53","PSA (ng/ml) at RRP: 13","Revised Gleason Score: 7","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 7.59206023271732","Second Rising PSA (ng/ml): 1.2","Time (yrs) from RRP to second rising PSA: 8.7501711156742","PSA Slope (ng/ml/yr): 0.863475177304964","Time (yrs) from PSA recurrence to systemic disease: 3.98083504449008","Years of Followup after RRP: 17.5167693360712","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-433","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268652/GSM268652_1559931034_R006_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268652/GSM268652_1559931034_R006_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268652/GSM268652_1559931034_R006_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268652/GSM268652_1559931034_R006_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268652/GSM268652_1559931034_R006_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268652/GSM268652_1559931034_R006_C008_Red.xml.gz","526"
"GSM268653","Patient 442 Core Set (custom panel)","GSM268653","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 6.5160848733744","Second Rising PSA (ng/ml): 2.2","Time (yrs) from RRP to second rising PSA: 7.4880219028063","PSA Slope (ng/ml/yr): 1.54330985915493","Time (yrs) from PSA recurrence to systemic disease: 4.05749486652977","Years of Followup after RRP: 16.5119780971937","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-442","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268653/GSM268653_1559931034_R006_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268653/GSM268653_1559931034_R006_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268653/GSM268653_1559931034_R006_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268653/GSM268653_1559931034_R006_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268653/GSM268653_1559931034_R006_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268653/GSM268653_1559931034_R006_C009_Red.xml.gz","526"
"GSM268654","Patient 450 Core Set (custom panel)","GSM268654","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 11.6","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.0479123887748","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-450","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268654/GSM268654_1559931034_R006_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268654/GSM268654_1559931034_R006_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268654/GSM268654_1559931034_R006_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268654/GSM268654_1559931034_R006_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268654/GSM268654_1559931034_R006_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268654/GSM268654_1559931034_R006_C010_Red.xml.gz","526"
"GSM268655","Patient 457 Core Set (custom panel)","GSM268655","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 3.3","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.85352498288843","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-457","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268655/GSM268655_1559931034_R006_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268655/GSM268655_1559931034_R006_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268655/GSM268655_1559931034_R006_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268655/GSM268655_1559931034_R006_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268655/GSM268655_1559931034_R006_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268655/GSM268655_1559931034_R006_C011_Red.xml.gz","526"
"GSM268656","Patient 464 Core Set (custom panel)","GSM268656","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 8.4","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 6.63107460643395","Second Rising PSA (ng/ml): 2.5","Time (yrs) from RRP to second rising PSA: 7.63586584531143","PSA Slope (ng/ml/yr): 1.99046321525886","Time (yrs) from PSA recurrence to systemic disease: 2.93497604380561","Years of Followup after RRP: 13.0814510609172","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-464","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268656/GSM268656_1559931034_R006_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268656/GSM268656_1559931034_R006_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268656/GSM268656_1559931034_R006_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268656/GSM268656_1559931034_R006_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268656/GSM268656_1559931034_R006_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268656/GSM268656_1559931034_R006_C012_Red.xml.gz","526"
"GSM268657","Patient 075 Core Set (custom panel)","GSM268657","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 77","PSA (ng/ml) at RRP: 33.5","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to first rising PSA: 0.572210814510609","Second Rising PSA (ng/ml): 5.5","Time (yrs) from RRP to second rising PSA: 1.28131416837782","PSA Slope (ng/ml/yr): 6.91013513513514","Time (yrs) from PSA recurrence to systemic disease: 1.28678986995209","Years of Followup after RRP: 11.5838466803559","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-075","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268657/GSM268657_1559931034_R007_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268657/GSM268657_1559931034_R007_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268657/GSM268657_1559931034_R007_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268657/GSM268657_1559931034_R007_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268657/GSM268657_1559931034_R007_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268657/GSM268657_1559931034_R007_C001_Red.xml.gz","526"
"GSM268658","Patient 385 Core Set (custom panel)","GSM268658","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 6.7","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to first rising PSA: 4.44626967830253","Second Rising PSA (ng/ml): 3","Time (yrs) from RRP to second rising PSA: 5.48939082819986","PSA Slope (ng/ml/yr): 2.3007874015748","Time (yrs) from PSA recurrence to systemic disease: 2.01505817932923","Years of Followup after RRP: 10.6365503080082","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-385","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268658/GSM268658_1559931034_R007_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268658/GSM268658_1559931034_R007_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268658/GSM268658_1559931034_R007_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268658/GSM268658_1559931034_R007_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268658/GSM268658_1559931034_R007_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268658/GSM268658_1559931034_R007_C002_Red.xml.gz","526"
"GSM268659","Patient 393 Core Set (custom panel)","GSM268659","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 20.8","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 0.265571526351814","Second Rising PSA (ng/ml): 1.4","Time (yrs) from RRP to second rising PSA: 0.361396303901437","PSA Slope (ng/ml/yr): 12.3141428571429","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 5.55783709787817","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-393","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268659/GSM268659_1559931034_R007_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268659/GSM268659_1559931034_R007_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268659/GSM268659_1559931034_R007_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268659/GSM268659_1559931034_R007_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268659/GSM268659_1559931034_R007_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268659/GSM268659_1559931034_R007_C003_Red.xml.gz","526"
"GSM268660","Patient 401 Core Set (custom panel)","GSM268660","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 23.7","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to first rising PSA: 0.878850102669405","Second Rising PSA (ng/ml): 1.4","Time (yrs) from RRP to second rising PSA: 1.17453798767967","PSA Slope (ng/ml/yr): 2.70555555555556","Time (yrs) from PSA recurrence to systemic disease: 4.64887063655031","Years of Followup after RRP: 15.4496919917864","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-401","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268660/GSM268660_1559931034_R007_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268660/GSM268660_1559931034_R007_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268660/GSM268660_1559931034_R007_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268660/GSM268660_1559931034_R007_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268660/GSM268660_1559931034_R007_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268660/GSM268660_1559931034_R007_C004_Red.xml.gz","526"
"GSM268661","Patient 409 Core Set (custom panel)","GSM268661","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 20.8","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.9","Time (yrs) from RRP to first rising PSA: 0.996577686516085","Second Rising PSA (ng/ml): 4.2","Time (yrs) from RRP to second rising PSA: 1.59069130732375","PSA Slope (ng/ml/yr): 5.5544930875576","Time (yrs) from PSA recurrence to systemic disease: 3.85215605749487","Years of Followup after RRP: 11.1594798083504","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-409","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268661/GSM268661_1559931034_R007_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268661/GSM268661_1559931034_R007_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268661/GSM268661_1559931034_R007_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268661/GSM268661_1559931034_R007_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268661/GSM268661_1559931034_R007_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268661/GSM268661_1559931034_R007_C005_Red.xml.gz","526"
"GSM268662","Patient 417 Core Set (custom panel)","GSM268662","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 8.2","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 6.05338809034908","Second Rising PSA (ng/ml): 1.5","Time (yrs) from RRP to second rising PSA: 6.30527036276523","PSA Slope (ng/ml/yr): 3.17608695652174","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.27720739219713","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-417","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268662/GSM268662_1559931034_R007_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268662/GSM268662_1559931034_R007_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268662/GSM268662_1559931034_R007_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268662/GSM268662_1559931034_R007_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268662/GSM268662_1559931034_R007_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268662/GSM268662_1559931034_R007_C006_Red.xml.gz","526"
"GSM268663","Patient 425 Core Set (custom panel)","GSM268663","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 24.4","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 6.5","Time (yrs) from RRP to first rising PSA: 0.246406570841889","Second Rising PSA (ng/ml): 7.5","Time (yrs) from RRP to second rising PSA: 0.473648186173854","PSA Slope (ng/ml/yr): 4.40060240963855","Time (yrs) from PSA recurrence to systemic disease: 2.16563997262149","Years of Followup after RRP: 3.00342231348392","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-425","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268663/GSM268663_1559931034_R007_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268663/GSM268663_1559931034_R007_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268663/GSM268663_1559931034_R007_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268663/GSM268663_1559931034_R007_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268663/GSM268663_1559931034_R007_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268663/GSM268663_1559931034_R007_C007_Red.xml.gz","526"
"GSM268664","Patient 434 Core Set (custom panel)","GSM268664","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 16.9","Revised Gleason Score: 5","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.19028062970568","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 2.31348391512663","PSA Slope (ng/ml/yr): 1.62333333333333","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.0513347022587","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-434","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268664/GSM268664_1559931034_R007_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268664/GSM268664_1559931034_R007_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268664/GSM268664_1559931034_R007_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268664/GSM268664_1559931034_R007_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268664/GSM268664_1559931034_R007_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268664/GSM268664_1559931034_R007_C008_Red.xml.gz","526"
"GSM268665","Patient 443 Core Set (custom panel)","GSM268665","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 8.4","Revised Gleason Score: 7","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.4585900068446","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-443","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268665/GSM268665_1559931034_R007_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268665/GSM268665_1559931034_R007_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268665/GSM268665_1559931034_R007_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268665/GSM268665_1559931034_R007_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268665/GSM268665_1559931034_R007_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268665/GSM268665_1559931034_R007_C009_Red.xml.gz","526"
"GSM268666","Patient 451 Core Set (custom panel)","GSM268666","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 21.2","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.5585215605749","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-451","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268666/GSM268666_1559931034_R007_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268666/GSM268666_1559931034_R007_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268666/GSM268666_1559931034_R007_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268666/GSM268666_1559931034_R007_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268666/GSM268666_1559931034_R007_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268666/GSM268666_1559931034_R007_C010_Red.xml.gz","526"
"GSM268667","Patient 458 Core Set (custom panel)","GSM268667","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.210814510609172","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 0.616016427104723","PSA Slope (ng/ml/yr): 0.740371621621622","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.4674880219028","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-458","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268667/GSM268667_1559931034_R007_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268667/GSM268667_1559931034_R007_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268667/GSM268667_1559931034_R007_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268667/GSM268667_1559931034_R007_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268667/GSM268667_1559931034_R007_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268667/GSM268667_1559931034_R007_C011_Red.xml.gz","526"
"GSM268668","Patient 465 Core Set (custom panel)","GSM268668","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 49","PSA (ng/ml) at RRP: 3.1","Revised Gleason Score: 6","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.79","Time (yrs) from RRP to first rising PSA: 2.48049281314168","Second Rising PSA (ng/ml): 3","Time (yrs) from RRP to second rising PSA: 2.98973305954825","PSA Slope (ng/ml/yr): 4.33979838709677","Time (yrs) from PSA recurrence to systemic disease: 0.769336071184121","Years of Followup after RRP: 10.0643394934976","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-465","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268668/GSM268668_1559931034_R007_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268668/GSM268668_1559931034_R007_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268668/GSM268668_1559931034_R007_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268668/GSM268668_1559931034_R007_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268668/GSM268668_1559931034_R007_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268668/GSM268668_1559931034_R007_C012_Red.xml.gz","526"
"GSM268669","Patient 379 Core Set (custom panel)","GSM268669","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: 2.1","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.3340177960301","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-379","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268669/GSM268669_1559931034_R008_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268669/GSM268669_1559931034_R008_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268669/GSM268669_1559931034_R008_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268669/GSM268669_1559931034_R008_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268669/GSM268669_1559931034_R008_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268669/GSM268669_1559931034_R008_C001_Red.xml.gz","526"
"GSM268670","Patient 386 Core Set (custom panel)","GSM268670","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 75","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.49691991786448","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 3.37303216974675","PSA Slope (ng/ml/yr): 0.342421875","Time (yrs) from PSA recurrence to systemic disease: 2.01505817932923","Years of Followup after RRP: 5.95482546201232","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-386","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268670/GSM268670_1559931034_R008_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268670/GSM268670_1559931034_R008_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268670/GSM268670_1559931034_R008_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268670/GSM268670_1559931034_R008_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268670/GSM268670_1559931034_R008_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268670/GSM268670_1559931034_R008_C002_Red.xml.gz","526"
"GSM268671","Patient 394 Core Set (custom panel)","GSM268671","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 61","PSA (ng/ml) at RRP: 7.8","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.9233401779603","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-394","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268671/GSM268671_1559931034_R008_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268671/GSM268671_1559931034_R008_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268671/GSM268671_1559931034_R008_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268671/GSM268671_1559931034_R008_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268671/GSM268671_1559931034_R008_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268671/GSM268671_1559931034_R008_C003_Red.xml.gz","526"
"GSM268672","Patient 402 Core Set (custom panel)","GSM268672","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 2.5","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 1.31416837782341","Second Rising PSA (ng/ml): 0.55","Time (yrs) from RRP to second rising PSA: 1.56331279945243","PSA Slope (ng/ml/yr): 1.32453296703297","Time (yrs) from PSA recurrence to systemic disease: 2.58179329226557","Years of Followup after RRP: 4.78850102669405","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-402","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268672/GSM268672_1559931034_R008_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268672/GSM268672_1559931034_R008_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268672/GSM268672_1559931034_R008_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268672/GSM268672_1559931034_R008_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268672/GSM268672_1559931034_R008_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268672/GSM268672_1559931034_R008_C004_Red.xml.gz","526"
"GSM268673","Patient 410 Core Set (custom panel)","GSM268673","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 11.7","Revised Gleason Score: 6","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 0.569472963723477","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 0.974674880219028","PSA Slope (ng/ml/yr): 0.493581081081081","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.6297056810404","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-410","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268673/GSM268673_1559931034_R008_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268673/GSM268673_1559931034_R008_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268673/GSM268673_1559931034_R008_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268673/GSM268673_1559931034_R008_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268673/GSM268673_1559931034_R008_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268673/GSM268673_1559931034_R008_C005_Red.xml.gz","526"
"GSM268674","Patient 418 Core Set (custom panel)","GSM268674","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 9","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.74","Time (yrs) from RRP to first rising PSA: 3.59479808350445","Second Rising PSA (ng/ml): 0.88","Time (yrs) from RRP to second rising PSA: 3.92881587953457","PSA Slope (ng/ml/yr): 0.419139344262295","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.6139630390144","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-418","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268674/GSM268674_1559931034_R008_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268674/GSM268674_1559931034_R008_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268674/GSM268674_1559931034_R008_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268674/GSM268674_1559931034_R008_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268674/GSM268674_1559931034_R008_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268674/GSM268674_1559931034_R008_C006_Red.xml.gz","526"
"GSM268675","Patient 426 Core Set (custom panel)","GSM268675","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 55","PSA (ng/ml) at RRP: 18.8","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 0.607802874743327","Second Rising PSA (ng/ml): 0.8","Time (yrs) from RRP to second rising PSA: 0.900752908966461","PSA Slope (ng/ml/yr): 1.70677570093458","Time (yrs) from PSA recurrence to systemic disease: 0.42984257357974","Years of Followup after RRP: 1.96851471594798","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-426","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268675/GSM268675_1559931034_R008_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268675/GSM268675_1559931034_R008_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268675/GSM268675_1559931034_R008_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268675/GSM268675_1559931034_R008_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268675/GSM268675_1559931034_R008_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268675/GSM268675_1559931034_R008_C007_Red.xml.gz","526"
"GSM268676","Patient 444 Core Set (custom panel)","GSM268676","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 8.09582477754962","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 9.32238193018481","PSA Slope (ng/ml/yr): 0.244587053571429","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.1156741957563","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-444","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268676/GSM268676_1559931034_R008_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268676/GSM268676_1559931034_R008_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268676/GSM268676_1559931034_R008_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268676/GSM268676_1559931034_R008_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268676/GSM268676_1559931034_R008_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268676/GSM268676_1559931034_R008_C009_Red.xml.gz","526"
"GSM268677","Patient 459 Core Set (custom panel)","GSM268677","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 5.5","Revised Gleason Score: 8","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.63791923340178","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-459","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268677/GSM268677_1559931034_R008_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268677/GSM268677_1559931034_R008_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268677/GSM268677_1559931034_R008_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268677/GSM268677_1559931034_R008_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268677/GSM268677_1559931034_R008_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268677/GSM268677_1559931034_R008_C011_Red.xml.gz","526"
"GSM268678","Patient 466 Core Set (custom panel)","GSM268678","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 13.9","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.58","Time (yrs) from RRP to first rising PSA: 2.04517453798768","Second Rising PSA (ng/ml): 0.66","Time (yrs) from RRP to second rising PSA: 2.05886379192334","PSA Slope (ng/ml/yr): 5.84400000000001","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.54140999315537","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-466","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268678/GSM268678_1559931034_R008_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268678/GSM268678_1559931034_R008_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268678/GSM268678_1559931034_R008_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268678/GSM268678_1559931034_R008_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268678/GSM268678_1559931034_R008_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268678/GSM268678_1559931034_R008_C012_Red.xml.gz","526"
"GSM268679","Patient 469 Core Set (custom panel)","GSM268679","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 76","PSA (ng/ml) at RRP: 75","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 1.1","Time (yrs) from RRP to first rising PSA: 0.714579055441478","Second Rising PSA (ng/ml): 2.2","Time (yrs) from RRP to second rising PSA: 0.991101984941821","PSA Slope (ng/ml/yr): 3.9779702970297","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.1800136892539","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-469","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268679/GSM268679_1559931037_R001_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268679/GSM268679_1559931037_R001_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268679/GSM268679_1559931037_R001_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268679/GSM268679_1559931037_R001_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268679/GSM268679_1559931037_R001_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268679/GSM268679_1559931037_R001_C002_Red.xml.gz","526"
"GSM268680","Patient 483 Core Set (custom panel)","GSM268680","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 15.3","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 0.517453798767967","Second Rising PSA (ng/ml): 1.3","Time (yrs) from RRP to second rising PSA: 1.45106091718001","PSA Slope (ng/ml/yr): 1.15680351906158","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.709787816564","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-483","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268680/GSM268680_1559931037_R001_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268680/GSM268680_1559931037_R001_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268680/GSM268680_1559931037_R001_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268680/GSM268680_1559931037_R001_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268680/GSM268680_1559931037_R001_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268680/GSM268680_1559931037_R001_C004_Red.xml.gz","526"
"GSM268681","Patient 492 Core Set (custom panel)","GSM268681","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 14","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.11635865845311","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 3.01163586584531","PSA Slope (ng/ml/yr): 0.111697247706422","Time (yrs) from PSA recurrence to systemic disease: 2.95414099931554","Years of Followup after RRP: 9.08966461327858","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-492","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268681/GSM268681_1559931037_R001_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268681/GSM268681_1559931037_R001_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268681/GSM268681_1559931037_R001_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268681/GSM268681_1559931037_R001_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268681/GSM268681_1559931037_R001_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268681/GSM268681_1559931037_R001_C005_Red.xml.gz","526"
"GSM268682","Patient 500 Core Set (custom panel)","GSM268682","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 16.5","Revised Gleason Score: 10","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 7","Time (yrs) from RRP to first rising PSA: 0.476386036960986","Second Rising PSA (ng/ml): 11.4","Time (yrs) from RRP to second rising PSA: 1.03764544832307","PSA Slope (ng/ml/yr): 7.83951219512195","Time (yrs) from PSA recurrence to systemic disease: 1.22929500342231","Years of Followup after RRP: 4.93908281998631","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-500","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268682/GSM268682_1559931037_R001_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268682/GSM268682_1559931037_R001_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268682/GSM268682_1559931037_R001_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268682/GSM268682_1559931037_R001_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268682/GSM268682_1559931037_R001_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268682/GSM268682_1559931037_R001_C006_Red.xml.gz","526"
"GSM268683","Patient 508 Core Set (custom panel)","GSM268683","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 2.3","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to first rising PSA: 2.45037645448323","Second Rising PSA (ng/ml): 0.8","Time (yrs) from RRP to second rising PSA: 2.46954140999316","PSA Slope (ng/ml/yr): 10.4357142857143","Time (yrs) from PSA recurrence to systemic disease: 1.54962354551677","Years of Followup after RRP: 7.54551676933607","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-508","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268683/GSM268683_1559931037_R001_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268683/GSM268683_1559931037_R001_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268683/GSM268683_1559931037_R001_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268683/GSM268683_1559931037_R001_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268683/GSM268683_1559931037_R001_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268683/GSM268683_1559931037_R001_C007_Red.xml.gz","526"
"GSM268684","Patient 516 Core Set (custom panel)","GSM268684","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 7.1","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 0.31211498973306","Second Rising PSA (ng/ml): 1.4","Time (yrs) from RRP to second rising PSA: 0.435318275154004","PSA Slope (ng/ml/yr): 5.68166666666667","Time (yrs) from PSA recurrence to systemic disease: 2.95140314852841","Years of Followup after RRP: 4.99931553730322","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-516","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268684/GSM268684_1559931037_R001_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268684/GSM268684_1559931037_R001_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268684/GSM268684_1559931037_R001_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268684/GSM268684_1559931037_R001_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268684/GSM268684_1559931037_R001_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268684/GSM268684_1559931037_R001_C008_Red.xml.gz","526"
"GSM268685","Patient 524 Core Set (custom panel)","GSM268685","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 201","Revised Gleason Score: 8","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.276522929500342","Second Rising PSA (ng/ml): 0.9","Time (yrs) from RRP to second rising PSA: 0.544832306639288","PSA Slope (ng/ml/yr): 2.60892857142857","Time (yrs) from PSA recurrence to systemic disease: 5.87268993839836","Years of Followup after RRP: 12.8843258042437","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-524","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268685/GSM268685_1559931037_R001_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268685/GSM268685_1559931037_R001_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268685/GSM268685_1559931037_R001_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268685/GSM268685_1559931037_R001_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268685/GSM268685_1559931037_R001_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268685/GSM268685_1559931037_R001_C009_Red.xml.gz","526"
"GSM268686","Patient 548 Core Set (custom panel)","GSM268686","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 5.2","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.03422313483915","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 2.55441478439425","PSA Slope (ng/ml/yr): 0.384473684210526","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.6167008898015","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-548","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268686/GSM268686_1559931037_R001_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268686/GSM268686_1559931037_R001_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268686/GSM268686_1559931037_R001_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268686/GSM268686_1559931037_R001_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268686/GSM268686_1559931037_R001_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268686/GSM268686_1559931037_R001_C012_Red.xml.gz","526"
"GSM268687","Patient 470 Core Set (custom panel)","GSM268687","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 7.1","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 6.39014373716632","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-470","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268687/GSM268687_1559931037_R002_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268687/GSM268687_1559931037_R002_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268687/GSM268687_1559931037_R002_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268687/GSM268687_1559931037_R002_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268687/GSM268687_1559931037_R002_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268687/GSM268687_1559931037_R002_C002_Red.xml.gz","526"
"GSM268688","Patient 476 Core Set (custom panel)","GSM268688","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 6","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.68240930869268","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-476","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268688/GSM268688_1559931037_R002_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268688/GSM268688_1559931037_R002_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268688/GSM268688_1559931037_R002_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268688/GSM268688_1559931037_R002_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268688/GSM268688_1559931037_R002_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268688/GSM268688_1559931037_R002_C003_Red.xml.gz","526"
"GSM268689","Patient 484 Core Set (custom panel)","GSM268689","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 22","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.9924709103354","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-484","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268689/GSM268689_1559931037_R002_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268689/GSM268689_1559931037_R002_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268689/GSM268689_1559931037_R002_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268689/GSM268689_1559931037_R002_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268689/GSM268689_1559931037_R002_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268689/GSM268689_1559931037_R002_C004_Red.xml.gz","526"
"GSM268690","Patient 493 Core Set (custom panel)","GSM268690","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 47.4","Revised Gleason Score: 7","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.1964407939767","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-493","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268690/GSM268690_1559931037_R002_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268690/GSM268690_1559931037_R002_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268690/GSM268690_1559931037_R002_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268690/GSM268690_1559931037_R002_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268690/GSM268690_1559931037_R002_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268690/GSM268690_1559931037_R002_C005_Red.xml.gz","526"
"GSM268691","Patient 501 Core Set (custom panel)","GSM268691","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 12.2","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.3340177960301","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-501","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268691/GSM268691_1559931037_R002_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268691/GSM268691_1559931037_R002_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268691/GSM268691_1559931037_R002_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268691/GSM268691_1559931037_R002_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268691/GSM268691_1559931037_R002_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268691/GSM268691_1559931037_R002_C006_Red.xml.gz","526"
"GSM268692","Patient 509 Core Set (custom panel)","GSM268692","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 25","Revised Gleason Score: 8","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 1.1","Time (yrs) from RRP to first rising PSA: 5.31690622861054","Second Rising PSA (ng/ml): 2","Time (yrs) from RRP to second rising PSA: 5.72758384668036","PSA Slope (ng/ml/yr): 2.1915","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.5290896646133","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-509","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268692/GSM268692_1559931037_R002_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268692/GSM268692_1559931037_R002_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268692/GSM268692_1559931037_R002_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268692/GSM268692_1559931037_R002_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268692/GSM268692_1559931037_R002_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268692/GSM268692_1559931037_R002_C007_Red.xml.gz","526"
"GSM268693","Patient 525 Core Set (custom panel)","GSM268693","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 53","PSA (ng/ml) at RRP: 2.3","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.555099247091","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-525","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268693/GSM268693_1559931037_R002_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268693/GSM268693_1559931037_R002_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268693/GSM268693_1559931037_R002_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268693/GSM268693_1559931037_R002_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268693/GSM268693_1559931037_R002_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268693/GSM268693_1559931037_R002_C009_Red.xml.gz","526"
"GSM268694","Patient 533 Core Set (custom panel)","GSM268694","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 8","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.36","Time (yrs) from RRP to first rising PSA: 2.11088295687885","Second Rising PSA (ng/ml): 1.2","Time (yrs) from RRP to second rising PSA: 2.71321013004791","PSA Slope (ng/ml/yr): 1.39459090909091","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.870636550308","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-533","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268694/GSM268694_1559931037_R002_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268694/GSM268694_1559931037_R002_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268694/GSM268694_1559931037_R002_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268694/GSM268694_1559931037_R002_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268694/GSM268694_1559931037_R002_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268694/GSM268694_1559931037_R002_C010_Red.xml.gz","526"
"GSM268695","Patient 541 Core Set (custom panel)","GSM268695","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 89.2","Revised Gleason Score: 8","Stage: TxN+","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 4.50650239561944","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 5.02943189596167","PSA Slope (ng/ml/yr): 0.191230366492147","Time (yrs) from PSA recurrence to systemic disease: 3.20876112251882","Years of Followup after RRP: 10.3846680355921","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-541","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268695/GSM268695_1559931037_R002_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268695/GSM268695_1559931037_R002_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268695/GSM268695_1559931037_R002_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268695/GSM268695_1559931037_R002_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268695/GSM268695_1559931037_R002_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268695/GSM268695_1559931037_R002_C011_Red.xml.gz","526"
"GSM268696","Patient 549 Core Set (custom panel)","GSM268696","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 10.4","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.24229979466119","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 3.2580424366872","PSA Slope (ng/ml/yr): 0.196900269541779","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.8240930869268","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-549","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268696/GSM268696_1559931037_R002_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268696/GSM268696_1559931037_R002_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268696/GSM268696_1559931037_R002_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268696/GSM268696_1559931037_R002_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268696/GSM268696_1559931037_R002_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268696/GSM268696_1559931037_R002_C012_Red.xml.gz","526"
"GSM268697","Patient 097 Core Set (custom panel)","GSM268697","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 2.8","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.6208076659822","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-097","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268697/GSM268697_1559931037_R003_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268697/GSM268697_1559931037_R003_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268697/GSM268697_1559931037_R003_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268697/GSM268697_1559931037_R003_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268697/GSM268697_1559931037_R003_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268697/GSM268697_1559931037_R003_C001_Red.xml.gz","526"
"GSM268698","Patient 471 Core Set (custom panel)","GSM268698","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 15.1","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 0.265571526351814","Second Rising PSA (ng/ml): 1","Time (yrs) from RRP to second rising PSA: 0.780287474332649","PSA Slope (ng/ml/yr): 1.1656914893617","Time (yrs) from PSA recurrence to systemic disease: 2.20396988364134","Years of Followup after RRP: 17.5578370978782","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-471","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268698/GSM268698_1559931037_R003_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268698/GSM268698_1559931037_R003_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268698/GSM268698_1559931037_R003_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268698/GSM268698_1559931037_R003_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268698/GSM268698_1559931037_R003_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268698/GSM268698_1559931037_R003_C002_Red.xml.gz","526"
"GSM268699","Patient 477 Core Set (custom panel)","GSM268699","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 6","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.2970568104038","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-477","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268699/GSM268699_1559931037_R003_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268699/GSM268699_1559931037_R003_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268699/GSM268699_1559931037_R003_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268699/GSM268699_1559931037_R003_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268699/GSM268699_1559931037_R003_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268699/GSM268699_1559931037_R003_C003_Red.xml.gz","526"
"GSM268700","Patient 485 Core Set (custom panel)","GSM268700","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 25.8","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.52","Time (yrs) from RRP to first rising PSA: 1.7056810403833","Second Rising PSA (ng/ml): 1.6","Time (yrs) from RRP to second rising PSA: 2.13004791238877","PSA Slope (ng/ml/yr): 2.54496774193548","Time (yrs) from PSA recurrence to systemic disease: 1.88637919233402","Years of Followup after RRP: 5.09787816563997","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-485","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268700/GSM268700_1559931037_R003_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268700/GSM268700_1559931037_R003_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268700/GSM268700_1559931037_R003_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268700/GSM268700_1559931037_R003_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268700/GSM268700_1559931037_R003_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268700/GSM268700_1559931037_R003_C004_Red.xml.gz","526"
"GSM268701","Patient 494 Core Set (custom panel)","GSM268701","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 40.1","Revised Gleason Score: 9","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 1","Time (yrs) from RRP to first rising PSA: 0.878850102669405","Second Rising PSA (ng/ml): 1.2","Time (yrs) from RRP to second rising PSA: 1.07323750855578","PSA Slope (ng/ml/yr): 1.02887323943662","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.77275838466804","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-494","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268701/GSM268701_1559931037_R003_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268701/GSM268701_1559931037_R003_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268701/GSM268701_1559931037_R003_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268701/GSM268701_1559931037_R003_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268701/GSM268701_1559931037_R003_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268701/GSM268701_1559931037_R003_C005_Red.xml.gz","526"
"GSM268702","Patient 510 Core Set (custom panel)","GSM268702","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 4.9","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 2.58726899383984","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 2.92950034223135","PSA Slope (ng/ml/yr): 0.8766","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.50924024640657","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-510","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268702/GSM268702_1559931037_R003_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268702/GSM268702_1559931037_R003_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268702/GSM268702_1559931037_R003_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268702/GSM268702_1559931037_R003_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268702/GSM268702_1559931037_R003_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268702/GSM268702_1559931037_R003_C007_Red.xml.gz","526"
"GSM268703","Patient 518 Core Set (custom panel)","GSM268703","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 47.2","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.0150581793292","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-518","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268703/GSM268703_1559931037_R003_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268703/GSM268703_1559931037_R003_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268703/GSM268703_1559931037_R003_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268703/GSM268703_1559931037_R003_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268703/GSM268703_1559931037_R003_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268703/GSM268703_1559931037_R003_C008_Red.xml.gz","526"
"GSM268704","Patient 534 Core Set (custom panel)","GSM268704","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 4.3","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to first rising PSA: 2.62833675564682","Second Rising PSA (ng/ml): 2.2","Time (yrs) from RRP to second rising PSA: 3.78097193702943","PSA Slope (ng/ml/yr): 1.30136579572447","Time (yrs) from PSA recurrence to systemic disease: 0.281998631074606","Years of Followup after RRP: 7.59479808350445","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-534","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268704/GSM268704_1559931037_R003_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268704/GSM268704_1559931037_R003_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268704/GSM268704_1559931037_R003_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268704/GSM268704_1559931037_R003_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268704/GSM268704_1559931037_R003_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268704/GSM268704_1559931037_R003_C010_Red.xml.gz","526"
"GSM268705","Patient 542 Core Set (custom panel)","GSM268705","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 59","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 7","Stage: T2N0","Ploidy: NA","First Rising PSA (ng/ml): 0.27","Time (yrs) from RRP to first rising PSA: 10.5845311430527","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 11.772758384668","PSA Slope (ng/ml/yr): 0.10940668202765","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.9014373716632","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-542","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268705/GSM268705_1559931037_R003_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268705/GSM268705_1559931037_R003_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268705/GSM268705_1559931037_R003_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268705/GSM268705_1559931037_R003_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268705/GSM268705_1559931037_R003_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268705/GSM268705_1559931037_R003_C011_Red.xml.gz","526"
"GSM268706","Patient 550 Core Set (custom panel)","GSM268706","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.10198494182067","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-550","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268706/GSM268706_1559931037_R003_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268706/GSM268706_1559931037_R003_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268706/GSM268706_1559931037_R003_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268706/GSM268706_1559931037_R003_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268706/GSM268706_1559931037_R003_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268706/GSM268706_1559931037_R003_C012_Red.xml.gz","526"
"GSM268707","Patient 472 Core Set (custom panel)","GSM268707","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 7.8","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.766598220396988","Second Rising PSA (ng/ml): 0.38","Time (yrs) from RRP to second rising PSA: 1.24572210814511","PSA Slope (ng/ml/yr): 0.375685714285714","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 5.33607118412047","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-472","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268707/GSM268707_1559931037_R004_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268707/GSM268707_1559931037_R004_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268707/GSM268707_1559931037_R004_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268707/GSM268707_1559931037_R004_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268707/GSM268707_1559931037_R004_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268707/GSM268707_1559931037_R004_C002_Red.xml.gz","526"
"GSM268708","Patient 478 Core Set (custom panel)","GSM268708","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 13.8","Revised Gleason Score: 9","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.11430527036277","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 1.73305954825462","PSA Slope (ng/ml/yr): 0.161615044247788","Time (yrs) from PSA recurrence to systemic disease: 3.27173169062286","Years of Followup after RRP: 12.9418206707734","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-478","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268708/GSM268708_1559931037_R004_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268708/GSM268708_1559931037_R004_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268708/GSM268708_1559931037_R004_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268708/GSM268708_1559931037_R004_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268708/GSM268708_1559931037_R004_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268708/GSM268708_1559931037_R004_C003_Red.xml.gz","526"
"GSM268709","Patient 486 Core Set (custom panel)","GSM268709","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 9.7","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 6.72689938398357","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-486","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268709/GSM268709_1559931037_R004_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268709/GSM268709_1559931037_R004_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268709/GSM268709_1559931037_R004_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268709/GSM268709_1559931037_R004_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268709/GSM268709_1559931037_R004_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268709/GSM268709_1559931037_R004_C004_Red.xml.gz","526"
"GSM268710","Patient 495 Core Set (custom panel)","GSM268710","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 28.3","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.31895961670089","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 4.26557152635181","PSA Slope (ng/ml/yr): 0.0513713080168776","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.9883641341547","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-495","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268710/GSM268710_1559931037_R004_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268710/GSM268710_1559931037_R004_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268710/GSM268710_1559931037_R004_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268710/GSM268710_1559931037_R004_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268710/GSM268710_1559931037_R004_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268710/GSM268710_1559931037_R004_C005_Red.xml.gz","526"
"GSM268711","Patient 503 Core Set (custom panel)","GSM268711","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 15.9","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 0.31211498973306","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 0.709103353867214","PSA Slope (ng/ml/yr): 0.251896551724138","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 5.86721423682409","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-503","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268711/GSM268711_1559931037_R004_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268711/GSM268711_1559931037_R004_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268711/GSM268711_1559931037_R004_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268711/GSM268711_1559931037_R004_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268711/GSM268711_1559931037_R004_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268711/GSM268711_1559931037_R004_C006_Red.xml.gz","526"
"GSM268712","Patient 511 Core Set (custom panel)","GSM268712","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 5.2","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.7857631759069","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-511","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268712/GSM268712_1559931037_R004_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268712/GSM268712_1559931037_R004_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268712/GSM268712_1559931037_R004_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268712/GSM268712_1559931037_R004_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268712/GSM268712_1559931037_R004_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268712/GSM268712_1559931037_R004_C007_Red.xml.gz","526"
"GSM268713","Patient 519 Core Set (custom panel)","GSM268713","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 46.6","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.23","Time (yrs) from RRP to first rising PSA: 1.98767967145791","Second Rising PSA (ng/ml): 0.35","Time (yrs) from RRP to second rising PSA: 2.40383299110198","PSA Slope (ng/ml/yr): 0.288355263157895","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.67419575633128","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-519","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268713/GSM268713_1559931037_R004_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268713/GSM268713_1559931037_R004_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268713/GSM268713_1559931037_R004_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268713/GSM268713_1559931037_R004_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268713/GSM268713_1559931037_R004_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268713/GSM268713_1559931037_R004_C008_Red.xml.gz","526"
"GSM268714","Patient 527 Core Set (custom panel)","GSM268714","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 22.3","Revised Gleason Score: 7","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 11.9","Time (yrs) from RRP to first rising PSA: 9.36618754277892","Second Rising PSA (ng/ml): 14.2","Time (yrs) from RRP to second rising PSA: 9.46748802190281","PSA Slope (ng/ml/yr): 22.7047297297297","Time (yrs) from PSA recurrence to systemic disease: 0.416153319644079","Years of Followup after RRP: 11.6030116358658","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-527","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268714/GSM268714_1559931037_R004_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268714/GSM268714_1559931037_R004_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268714/GSM268714_1559931037_R004_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268714/GSM268714_1559931037_R004_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268714/GSM268714_1559931037_R004_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268714/GSM268714_1559931037_R004_C009_Red.xml.gz","526"
"GSM268715","Patient 536 Core Set (custom panel)","GSM268715","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 130","Revised Gleason Score: 8","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 4.1","Time (yrs) from RRP to first rising PSA: 0.643394934976044","Second Rising PSA (ng/ml): 24","Time (yrs) from RRP to second rising PSA: 2.94592744695414","PSA Slope (ng/ml/yr): 8.64265755053508","Time (yrs) from PSA recurrence to systemic disease: 0.232717316906229","Years of Followup after RRP: 5.72758384668036","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-536","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268715/GSM268715_1559931037_R004_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268715/GSM268715_1559931037_R004_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268715/GSM268715_1559931037_R004_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268715/GSM268715_1559931037_R004_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268715/GSM268715_1559931037_R004_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268715/GSM268715_1559931037_R004_C010_Red.xml.gz","526"
"GSM268716","Patient 543 Core Set (custom panel)","GSM268716","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 39.2","Revised Gleason Score: 7","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.9418206707734","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-543","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268716/GSM268716_1559931037_R004_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268716/GSM268716_1559931037_R004_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268716/GSM268716_1559931037_R004_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268716/GSM268716_1559931037_R004_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268716/GSM268716_1559931037_R004_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268716/GSM268716_1559931037_R004_C011_Red.xml.gz","526"
"GSM268717","Patient 551 Core Set (custom panel)","GSM268717","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 4.2","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.02258726899384","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-551","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268717/GSM268717_1559931037_R004_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268717/GSM268717_1559931037_R004_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268717/GSM268717_1559931037_R004_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268717/GSM268717_1559931037_R004_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268717/GSM268717_1559931037_R004_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268717/GSM268717_1559931037_R004_C012_Red.xml.gz","526"
"GSM268718","Patient 100 Core Set (custom panel)","GSM268718","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 55","PSA (ng/ml) at RRP: 15","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.37","Time (yrs) from RRP to first rising PSA: 9.90006844626968","Second Rising PSA (ng/ml): 0.44","Time (yrs) from RRP to second rising PSA: 10.90212183436","PSA Slope (ng/ml/yr): 0.0698565573770492","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.1533196440794","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-100","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268718/GSM268718_1559931037_R005_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268718/GSM268718_1559931037_R005_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268718/GSM268718_1559931037_R005_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268718/GSM268718_1559931037_R005_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268718/GSM268718_1559931037_R005_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268718/GSM268718_1559931037_R005_C001_Red.xml.gz","526"
"GSM268719","Patient 473 Core Set (custom panel)","GSM268719","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.284736481861739","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 0.919917864476386","PSA Slope (ng/ml/yr): 0.314870689655172","Time (yrs) from PSA recurrence to systemic disease: 2.8227241615332","Years of Followup after RRP: 9.04585900068446","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-473","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268719/GSM268719_1559931037_R005_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268719/GSM268719_1559931037_R005_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268719/GSM268719_1559931037_R005_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268719/GSM268719_1559931037_R005_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268719/GSM268719_1559931037_R005_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268719/GSM268719_1559931037_R005_C002_Red.xml.gz","526"
"GSM268720","Patient 479 Core Set (custom panel)","GSM268720","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 27","Revised Gleason Score: 7","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 3.02532511978097","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 4.36960985626283","PSA Slope (ng/ml/yr): 0.22316700610998","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.3203285420945","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-479","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268720/GSM268720_1559931037_R005_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268720/GSM268720_1559931037_R005_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268720/GSM268720_1559931037_R005_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268720/GSM268720_1559931037_R005_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268720/GSM268720_1559931037_R005_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268720/GSM268720_1559931037_R005_C003_Red.xml.gz","526"
"GSM268721","Patient 488 Core Set (custom panel)","GSM268721","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 4.7","Revised Gleason Score: 9","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.38","Time (yrs) from RRP to first rising PSA: 0.514715947980835","Second Rising PSA (ng/ml): 0.61","Time (yrs) from RRP to second rising PSA: 0.750171115674196","PSA Slope (ng/ml/yr): 0.976831395348837","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.1895961670089","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-488","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268721/GSM268721_1559931037_R005_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268721/GSM268721_1559931037_R005_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268721/GSM268721_1559931037_R005_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268721/GSM268721_1559931037_R005_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268721/GSM268721_1559931037_R005_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268721/GSM268721_1559931037_R005_C004_Red.xml.gz","526"
"GSM268722","Patient 496 Core Set (custom panel)","GSM268722","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 55","PSA (ng/ml) at RRP: 3.5","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.1820670773443","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-496","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268722/GSM268722_1559931037_R005_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268722/GSM268722_1559931037_R005_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268722/GSM268722_1559931037_R005_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268722/GSM268722_1559931037_R005_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268722/GSM268722_1559931037_R005_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268722/GSM268722_1559931037_R005_C005_Red.xml.gz","526"
"GSM268723","Patient 504 Core Set (custom panel)","GSM268723","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 53","PSA (ng/ml) at RRP: 5.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.37440109514031","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-504","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268723/GSM268723_1559931037_R005_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268723/GSM268723_1559931037_R005_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268723/GSM268723_1559931037_R005_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268723/GSM268723_1559931037_R005_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268723/GSM268723_1559931037_R005_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268723/GSM268723_1559931037_R005_C006_Red.xml.gz","526"
"GSM268724","Patient 512 Core Set (custom panel)","GSM268724","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 6.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 9.98220396988364","Second Rising PSA (ng/ml): 0.45","Time (yrs) from RRP to second rising PSA: 10.9733059548255","PSA Slope (ng/ml/yr): 0.151346685082873","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.5503080082136","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-512","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268724/GSM268724_1559931037_R005_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268724/GSM268724_1559931037_R005_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268724/GSM268724_1559931037_R005_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268724/GSM268724_1559931037_R005_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268724/GSM268724_1559931037_R005_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268724/GSM268724_1559931037_R005_C007_Red.xml.gz","526"
"GSM268725","Patient 520 Core Set (custom panel)","GSM268725","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 7.5","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.4168377823409","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-520","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268725/GSM268725_1559931037_R005_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268725/GSM268725_1559931037_R005_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268725/GSM268725_1559931037_R005_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268725/GSM268725_1559931037_R005_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268725/GSM268725_1559931037_R005_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268725/GSM268725_1559931037_R005_C008_Red.xml.gz","526"
"GSM268726","Patient 528 Core Set (custom panel)","GSM268726","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 74","PSA (ng/ml) at RRP: 12.2","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.90212183436","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-528","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268726/GSM268726_1559931037_R005_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268726/GSM268726_1559931037_R005_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268726/GSM268726_1559931037_R005_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268726/GSM268726_1559931037_R005_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268726/GSM268726_1559931037_R005_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268726/GSM268726_1559931037_R005_C009_Red.xml.gz","526"
"GSM268727","Patient 537 Core Set (custom panel)","GSM268727","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 9.9","Revised Gleason Score: 10","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 0.59","Time (yrs) from RRP to first rising PSA: 1.44832306639288","Second Rising PSA (ng/ml): 1.75","Time (yrs) from RRP to second rising PSA: 1.73032169746749","PSA Slope (ng/ml/yr): 4.11349514563107","Time (yrs) from PSA recurrence to systemic disease: 1.86995208761123","Years of Followup after RRP: 4.47364818617385","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-537","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268727/GSM268727_1559931037_R005_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268727/GSM268727_1559931037_R005_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268727/GSM268727_1559931037_R005_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268727/GSM268727_1559931037_R005_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268727/GSM268727_1559931037_R005_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268727/GSM268727_1559931037_R005_C010_Red.xml.gz","526"
"GSM268728","Patient 544 Core Set (custom panel)","GSM268728","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 9.3","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 2.46954140999316","Second Rising PSA (ng/ml): 1.1","Time (yrs) from RRP to second rising PSA: 3.0280629705681","PSA Slope (ng/ml/yr): 1.25330882352941","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.0910335386721","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-544","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268728/GSM268728_1559931037_R005_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268728/GSM268728_1559931037_R005_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268728/GSM268728_1559931037_R005_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268728/GSM268728_1559931037_R005_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268728/GSM268728_1559931037_R005_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268728/GSM268728_1559931037_R005_C011_Red.xml.gz","526"
"GSM268729","Patient 552 Core Set (custom panel)","GSM268729","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 9.8","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 0.355920602327173","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 0.58590006844627","PSA Slope (ng/ml/yr): 0.869642857142857","Time (yrs) from PSA recurrence to systemic disease: 0.295687885010267","Years of Followup after RRP: 4.78850102669405","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-552","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268729/GSM268729_1559931037_R005_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268729/GSM268729_1559931037_R005_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268729/GSM268729_1559931037_R005_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268729/GSM268729_1559931037_R005_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268729/GSM268729_1559931037_R005_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268729/GSM268729_1559931037_R005_C012_Red.xml.gz","526"
"GSM268730","Patient 112 Core Set (custom panel)","GSM268730","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 12.7","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.8357289527721","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-112","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268730/GSM268730_1559931037_R006_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268730/GSM268730_1559931037_R006_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268730/GSM268730_1559931037_R006_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268730/GSM268730_1559931037_R006_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268730/GSM268730_1559931037_R006_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268730/GSM268730_1559931037_R006_C001_Red.xml.gz","526"
"GSM268731","Patient 474 Core Set (custom panel)","GSM268731","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 4.8","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.2888432580424","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-474","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268731/GSM268731_1559931037_R006_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268731/GSM268731_1559931037_R006_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268731/GSM268731_1559931037_R006_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268731/GSM268731_1559931037_R006_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268731/GSM268731_1559931037_R006_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268731/GSM268731_1559931037_R006_C002_Red.xml.gz","526"
"GSM268732","Patient 489 Core Set (custom panel)","GSM268732","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 24.8","Revised Gleason Score: 7","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.9459274469541","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-489","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268732/GSM268732_1559931037_R006_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268732/GSM268732_1559931037_R006_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268732/GSM268732_1559931037_R006_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268732/GSM268732_1559931037_R006_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268732/GSM268732_1559931037_R006_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268732/GSM268732_1559931037_R006_C004_Red.xml.gz","526"
"GSM268733","Patient 497 Core Set (custom panel)","GSM268733","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 51","PSA (ng/ml) at RRP: 9.5","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 4.49555099247091","Second Rising PSA (ng/ml): 0.34","Time (yrs) from RRP to second rising PSA: 5.65092402464066","PSA Slope (ng/ml/yr): 0.121172985781991","Time (yrs) from PSA recurrence to systemic disease: 2.88021902806297","Years of Followup after RRP: 9.65913757700205","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-497","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268733/GSM268733_1559931037_R006_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268733/GSM268733_1559931037_R006_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268733/GSM268733_1559931037_R006_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268733/GSM268733_1559931037_R006_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268733/GSM268733_1559931037_R006_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268733/GSM268733_1559931037_R006_C005_Red.xml.gz","526"
"GSM268734","Patient 513 Core Set (custom panel)","GSM268734","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 5","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.0527036276523","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-513","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268734/GSM268734_1559931037_R006_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268734/GSM268734_1559931037_R006_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268734/GSM268734_1559931037_R006_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268734/GSM268734_1559931037_R006_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268734/GSM268734_1559931037_R006_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268734/GSM268734_1559931037_R006_C007_Red.xml.gz","526"
"GSM268735","Patient 521 Core Set (custom panel)","GSM268735","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 87","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 13.8","Time (yrs) from RRP to first rising PSA: 2.27789185489391","Second Rising PSA (ng/ml): 20.5","Time (yrs) from RRP to second rising PSA: 2.32717316906229","PSA Slope (ng/ml/yr): 135.954166666667","Time (yrs) from PSA recurrence to systemic disease: 3.15126625598905","Years of Followup after RRP: 7.31827515400411","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-521","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268735/GSM268735_1559931037_R006_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268735/GSM268735_1559931037_R006_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268735/GSM268735_1559931037_R006_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268735/GSM268735_1559931037_R006_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268735/GSM268735_1559931037_R006_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268735/GSM268735_1559931037_R006_C008_Red.xml.gz","526"
"GSM268736","Patient 529 Core Set (custom panel)","GSM268736","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 21.4","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.66735112936345","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 2.17659137577002","PSA Slope (ng/ml/yr): 0.392741935483871","Time (yrs) from PSA recurrence to systemic disease: 1.75496235455168","Years of Followup after RRP: 12.394250513347","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-529","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268736/GSM268736_1559931037_R006_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268736/GSM268736_1559931037_R006_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268736/GSM268736_1559931037_R006_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268736/GSM268736_1559931037_R006_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268736/GSM268736_1559931037_R006_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268736/GSM268736_1559931037_R006_C009_Red.xml.gz","526"
"GSM268737","Patient 538 Core Set (custom panel)","GSM268737","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 3.5","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.6995208761123","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-538","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268737/GSM268737_1559931037_R006_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268737/GSM268737_1559931037_R006_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268737/GSM268737_1559931037_R006_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268737/GSM268737_1559931037_R006_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268737/GSM268737_1559931037_R006_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268737/GSM268737_1559931037_R006_C010_Red.xml.gz","526"
"GSM268738","Patient 545 Core Set (custom panel)","GSM268738","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 6.1","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.3388090349076","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-545","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268738/GSM268738_1559931037_R006_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268738/GSM268738_1559931037_R006_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268738/GSM268738_1559931037_R006_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268738/GSM268738_1559931037_R006_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268738/GSM268738_1559931037_R006_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268738/GSM268738_1559931037_R006_C011_Red.xml.gz","526"
"GSM268739","Patient 553 Core Set (custom panel)","GSM268739","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 3","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.3990417522245","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 1.65092402464066","PSA Slope (ng/ml/yr): 0.397010869565217","Time (yrs) from PSA recurrence to systemic disease: 3.48528405201917","Years of Followup after RRP: 6.92128678986995","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-553","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268739/GSM268739_1559931037_R006_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268739/GSM268739_1559931037_R006_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268739/GSM268739_1559931037_R006_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268739/GSM268739_1559931037_R006_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268739/GSM268739_1559931037_R006_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268739/GSM268739_1559931037_R006_C012_Red.xml.gz","526"
"GSM268740","Patient 467 Core Set (custom panel)","GSM268740","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 12.5","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.55","Time (yrs) from RRP to first rising PSA: 8.18891170431212","Second Rising PSA (ng/ml): 1","Time (yrs) from RRP to second rising PSA: 9.76043805612594","PSA Slope (ng/ml/yr): 0.286345818815331","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.025325119781","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-467","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268740/GSM268740_1559931037_R007_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268740/GSM268740_1559931037_R007_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268740/GSM268740_1559931037_R007_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268740/GSM268740_1559931037_R007_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268740/GSM268740_1559931037_R007_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268740/GSM268740_1559931037_R007_C001_Red.xml.gz","526"
"GSM268741","Patient 475 Core Set (custom panel)","GSM268741","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 8.6","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 18.8","Time (yrs) from RRP to first rising PSA: 2.82546201232033","Second Rising PSA (ng/ml): 20.1","Time (yrs) from RRP to second rising PSA: 2.91581108829569","PSA Slope (ng/ml/yr): 14.3886363636364","Time (yrs) from PSA recurrence to systemic disease: 2.98699520876112","Years of Followup after RRP: 6.74058863791923","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-475","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268741/GSM268741_1559931037_R007_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268741/GSM268741_1559931037_R007_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268741/GSM268741_1559931037_R007_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268741/GSM268741_1559931037_R007_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268741/GSM268741_1559931037_R007_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268741/GSM268741_1559931037_R007_C002_Red.xml.gz","526"
"GSM268742","Patient 481 Core Set (custom panel)","GSM268742","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 21.4","Revised Gleason Score: 8","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 1.9","Time (yrs) from RRP to first rising PSA: 3.36481861738535","Second Rising PSA (ng/ml): 2.3","Time (yrs) from RRP to second rising PSA: 3.38945927446954","PSA Slope (ng/ml/yr): 16.2333333333333","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.10609171800137","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-481","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268742/GSM268742_1559931037_R007_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268742/GSM268742_1559931037_R007_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268742/GSM268742_1559931037_R007_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268742/GSM268742_1559931037_R007_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268742/GSM268742_1559931037_R007_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268742/GSM268742_1559931037_R007_C003_Red.xml.gz","526"
"GSM268743","Patient 490 Core Set (custom panel)","GSM268743","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 56","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 59","Time (yrs) from RRP to first rising PSA: 0.298425735797399","Second Rising PSA (ng/ml): 70","Time (yrs) from RRP to second rising PSA: 0.407939767282683","PSA Slope (ng/ml/yr): 100.44375","Time (yrs) from PSA recurrence to systemic disease: 0.774811772758385","Years of Followup after RRP: 8.76386036960986","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-490","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268743/GSM268743_1559931037_R007_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268743/GSM268743_1559931037_R007_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268743/GSM268743_1559931037_R007_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268743/GSM268743_1559931037_R007_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268743/GSM268743_1559931037_R007_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268743/GSM268743_1559931037_R007_C004_Red.xml.gz","526"
"GSM268744","Patient 498 Core Set (custom panel)","GSM268744","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 6.5","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.22313483915127","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 2.41752224503765","PSA Slope (ng/ml/yr): 0.51443661971831","Time (yrs) from PSA recurrence to systemic disease: 1.05407255304586","Years of Followup after RRP: 7.6249144421629","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-498","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268744/GSM268744_1559931037_R007_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268744/GSM268744_1559931037_R007_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268744/GSM268744_1559931037_R007_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268744/GSM268744_1559931037_R007_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268744/GSM268744_1559931037_R007_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268744/GSM268744_1559931037_R007_C005_Red.xml.gz","526"
"GSM268745","Patient 506 Core Set (custom panel)","GSM268745","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 15.4","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.0417522245038","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-506","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268745/GSM268745_1559931037_R007_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268745/GSM268745_1559931037_R007_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268745/GSM268745_1559931037_R007_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268745/GSM268745_1559931037_R007_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268745/GSM268745_1559931037_R007_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268745/GSM268745_1559931037_R007_C006_Red.xml.gz","526"
"GSM268746","Patient 514 Core Set (custom panel)","GSM268746","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 3.8","Revised Gleason Score: 6","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.37782340862423","Second Rising PSA (ng/ml): 1.2","Time (yrs) from RRP to second rising PSA: 10.715947980835","PSA Slope (ng/ml/yr): 0.096729343220339","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.3613963039014","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-514","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268746/GSM268746_1559931037_R007_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268746/GSM268746_1559931037_R007_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268746/GSM268746_1559931037_R007_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268746/GSM268746_1559931037_R007_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268746/GSM268746_1559931037_R007_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268746/GSM268746_1559931037_R007_C007_Red.xml.gz","526"
"GSM268747","Patient 522 Core Set (custom panel)","GSM268747","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 52","PSA (ng/ml) at RRP: 33.2","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.27","Time (yrs) from RRP to first rising PSA: 1.06228610540726","Second Rising PSA (ng/ml): 0.34","Time (yrs) from RRP to second rising PSA: 1.4757015742642","PSA Slope (ng/ml/yr): 0.16932119205298","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.44969199178645","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-522","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268747/GSM268747_1559931037_R007_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268747/GSM268747_1559931037_R007_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268747/GSM268747_1559931037_R007_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268747/GSM268747_1559931037_R007_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268747/GSM268747_1559931037_R007_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268747/GSM268747_1559931037_R007_C008_Red.xml.gz","526"
"GSM268748","Patient 530 Core Set (custom panel)","GSM268748","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 10.7","Revised Gleason Score: 8","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.818617385352498","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 1.02395619438741","PSA Slope (ng/ml/yr): 0.487","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.70431211498973","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-530","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268748/GSM268748_1559931037_R007_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268748/GSM268748_1559931037_R007_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268748/GSM268748_1559931037_R007_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268748/GSM268748_1559931037_R007_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268748/GSM268748_1559931037_R007_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268748/GSM268748_1559931037_R007_C009_Red.xml.gz","526"
"GSM268749","Patient 539 Core Set (custom panel)","GSM268749","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 56","PSA (ng/ml) at RRP: 21.4","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 3.12388774811773","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 3.64134154688569","PSA Slope (ng/ml/yr): 0.579761904761905","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.4250513347023","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-539","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268749/GSM268749_1559931037_R007_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268749/GSM268749_1559931037_R007_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268749/GSM268749_1559931037_R007_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268749/GSM268749_1559931037_R007_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268749/GSM268749_1559931037_R007_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268749/GSM268749_1559931037_R007_C010_Red.xml.gz","526"
"GSM268750","Patient 546 Core Set (custom panel)","GSM268750","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 11.4","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.21","Time (yrs) from RRP to first rising PSA: 2.90759753593429","Second Rising PSA (ng/ml): 0.77","Time (yrs) from RRP to second rising PSA: 3.46611909650924","PSA Slope (ng/ml/yr): 1.00264705882353","Time (yrs) from PSA recurrence to systemic disease: 0.476386036960986","Years of Followup after RRP: 5.61806981519507","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-546","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268750/GSM268750_1559931037_R007_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268750/GSM268750_1559931037_R007_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268750/GSM268750_1559931037_R007_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268750/GSM268750_1559931037_R007_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268750/GSM268750_1559931037_R007_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268750/GSM268750_1559931037_R007_C011_Red.xml.gz","526"
"GSM268751","Patient 468 Core Set (custom panel)","GSM268751","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 6.7","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.88774811772758","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-468","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268751/GSM268751_1559931037_R008_C001_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268751/GSM268751_1559931037_R008_C001_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268751/GSM268751_1559931037_R008_C001_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268751/GSM268751_1559931037_R008_C001_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268751/GSM268751_1559931037_R008_C001_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268751/GSM268751_1559931037_R008_C001_Red.xml.gz","526"
"GSM268752","Patient 482 Core Set (custom panel)","GSM268752","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 31.7","Revised Gleason Score: 8","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.62","Time (yrs) from RRP to first rising PSA: 2.99794661190965","Second Rising PSA (ng/ml): 1.1","Time (yrs) from RRP to second rising PSA: 3.4798083504449","PSA Slope (ng/ml/yr): 0.996136363636364","Time (yrs) from PSA recurrence to systemic disease: 4.89253935660506","Years of Followup after RRP: 10.7707049965777","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-482","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268752/GSM268752_1559931037_R008_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268752/GSM268752_1559931037_R008_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268752/GSM268752_1559931037_R008_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268752/GSM268752_1559931037_R008_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268752/GSM268752_1559931037_R008_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268752/GSM268752_1559931037_R008_C003_Red.xml.gz","526"
"GSM268753","Patient 491 Core Set (custom panel)","GSM268753","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 42.6","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to first rising PSA: 0.375085557837098","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 0.528405201916496","PSA Slope (ng/ml/yr): 0.652232142857143","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.2347707049966","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-491","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268753/GSM268753_1559931037_R008_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268753/GSM268753_1559931037_R008_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268753/GSM268753_1559931037_R008_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268753/GSM268753_1559931037_R008_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268753/GSM268753_1559931037_R008_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268753/GSM268753_1559931037_R008_C004_Red.xml.gz","526"
"GSM268754","Patient 499 Core Set (custom panel)","GSM268754","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 71","PSA (ng/ml) at RRP: 31.7","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 5.45379876796715","Second Rising PSA (ng/ml): 5.3","Time (yrs) from RRP to second rising PSA: 8.85420944558522","PSA Slope (ng/ml/yr): 1.49981884057971","Time (yrs) from PSA recurrence to systemic disease: 2.0643394934976","Years of Followup after RRP: 14.0999315537303","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-499","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268754/GSM268754_1559931037_R008_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268754/GSM268754_1559931037_R008_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268754/GSM268754_1559931037_R008_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268754/GSM268754_1559931037_R008_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268754/GSM268754_1559931037_R008_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268754/GSM268754_1559931037_R008_C005_Red.xml.gz","526"
"GSM268755","Patient 507 Core Set (custom panel)","GSM268755","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 64","PSA (ng/ml) at RRP: 5.7","Revised Gleason Score: 9","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 3","Time (yrs) from RRP to first rising PSA: 2.08624229979466","Second Rising PSA (ng/ml): 7.2","Time (yrs) from RRP to second rising PSA: 2.42026009582478","PSA Slope (ng/ml/yr): 12.5741803278689","Time (yrs) from PSA recurrence to systemic disease: 2.57357973990418","Years of Followup after RRP: 6.6009582477755","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-507","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268755/GSM268755_1559931037_R008_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268755/GSM268755_1559931037_R008_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268755/GSM268755_1559931037_R008_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268755/GSM268755_1559931037_R008_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268755/GSM268755_1559931037_R008_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268755/GSM268755_1559931037_R008_C006_Red.xml.gz","526"
"GSM268756","Patient 515 Core Set (custom panel)","GSM268756","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 57","PSA (ng/ml) at RRP: 31","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): 1.9","Time (yrs) from RRP to first rising PSA: 3.03080082135524","Second Rising PSA (ng/ml): 2.1","Time (yrs) from RRP to second rising PSA: 3.30184804928131","PSA Slope (ng/ml/yr): 0.737878787878788","Time (yrs) from PSA recurrence to systemic disease: 3.58658453114305","Years of Followup after RRP: 7.85215605749487","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-515","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268756/GSM268756_1559931037_R008_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268756/GSM268756_1559931037_R008_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268756/GSM268756_1559931037_R008_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268756/GSM268756_1559931037_R008_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268756/GSM268756_1559931037_R008_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268756/GSM268756_1559931037_R008_C007_Red.xml.gz","526"
"GSM268757","Patient 523 Core Set (custom panel)","GSM268757","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 76","PSA (ng/ml) at RRP: 8.9","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.23","Time (yrs) from RRP to first rising PSA: 8.94182067077344","Second Rising PSA (ng/ml): 1.8","Time (yrs) from RRP to second rising PSA: 9.9356605065024","PSA Slope (ng/ml/yr): 1.57973140495868","Time (yrs) from PSA recurrence to systemic disease: 0.960985626283368","Years of Followup after RRP: 14.3107460643395","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-523","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268757/GSM268757_1559931037_R008_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268757/GSM268757_1559931037_R008_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268757/GSM268757_1559931037_R008_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268757/GSM268757_1559931037_R008_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268757/GSM268757_1559931037_R008_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268757/GSM268757_1559931037_R008_C008_Red.xml.gz","526"
"GSM268758","Patient 531 Core Set (custom panel)","GSM268758","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 9","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.5975359342916","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-531","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268758/GSM268758_1559931037_R008_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268758/GSM268758_1559931037_R008_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268758/GSM268758_1559931037_R008_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268758/GSM268758_1559931037_R008_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268758/GSM268758_1559931037_R008_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268758/GSM268758_1559931037_R008_C009_Red.xml.gz","526"
"GSM268759","Patient 540 Core Set (custom panel)","GSM268759","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 14.6","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.563997262149213","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 0.835044490075291","PSA Slope (ng/ml/yr): 0.368939393939394","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.84394250513347","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-540","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268759/GSM268759_1559931037_R008_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268759/GSM268759_1559931037_R008_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268759/GSM268759_1559931037_R008_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268759/GSM268759_1559931037_R008_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268759/GSM268759_1559931037_R008_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268759/GSM268759_1559931037_R008_C010_Red.xml.gz","526"
"GSM268760","Patient 547 Core Set (custom panel)","GSM268760","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 8","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 0.848733744010951","Second Rising PSA (ng/ml): 0.39","Time (yrs) from RRP to second rising PSA: 1.11156741957563","PSA Slope (ng/ml/yr): 0.342421875","Time (yrs) from PSA recurrence to systemic disease: 0.257357973990418","Years of Followup after RRP: 2.50513347022587","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-547","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268760/GSM268760_1559931037_R008_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268760/GSM268760_1559931037_R008_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268760/GSM268760_1559931037_R008_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268760/GSM268760_1559931037_R008_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268760/GSM268760_1559931037_R008_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268760/GSM268760_1559931037_R008_C011_Red.xml.gz","526"
"GSM268761","Patient 554 Core Set (custom panel)","GSM268761","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 4.4","Revised Gleason Score: 8","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 1.30595482546201","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 2.92950034223135","PSA Slope (ng/ml/yr): 0.307967959527825","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 12.3367556468172","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-554","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268761/GSM268761_1559931037_R008_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268761/GSM268761_1559931037_R008_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268761/GSM268761_1559931037_R008_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268761/GSM268761_1559931037_R008_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268761/GSM268761_1559931037_R008_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268761/GSM268761_1559931037_R008_C012_Red.xml.gz","526"
"GSM268762","Patient 179 Core Set (custom panel)","GSM268762","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 10.7","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 2.3025325119781","Second Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to second rising PSA: 2.79808350444901","PSA Slope (ng/ml/yr): 0.201795580110497","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 17.3278576317591","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-179","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268762/GSM268762_1602767002_R001_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268762/GSM268762_1602767002_R001_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268762/GSM268762_1602767002_R001_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268762/GSM268762_1602767002_R001_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268762/GSM268762_1602767002_R001_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268762/GSM268762_1602767002_R001_C002_Red.xml.gz","526"
"GSM268763","Patient 570 Core Set (custom panel)","GSM268763","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 68","PSA (ng/ml) at RRP: 12","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.3","Time (yrs) from RRP to first rising PSA: 1.52498288843258","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 2.10266940451745","PSA Slope (ng/ml/yr): 0.692417061611374","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 10.1409993155373","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-570","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268763/GSM268763_1602767002_R001_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268763/GSM268763_1602767002_R001_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268763/GSM268763_1602767002_R001_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268763/GSM268763_1602767002_R001_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268763/GSM268763_1602767002_R001_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268763/GSM268763_1602767002_R001_C004_Red.xml.gz","526"
"GSM268764","Patient 578 Core Set (custom panel)","GSM268764","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 10.9","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: aneuploid","First Rising PSA (ng/ml): 1.6","Time (yrs) from RRP to first rising PSA: 0.509240246406571","Second Rising PSA (ng/ml): 2.9","Time (yrs) from RRP to second rising PSA: 0.747433264887064","PSA Slope (ng/ml/yr): 5.45775862068965","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.50444900752909","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-578","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268764/GSM268764_1602767002_R001_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268764/GSM268764_1602767002_R001_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268764/GSM268764_1602767002_R001_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268764/GSM268764_1602767002_R001_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268764/GSM268764_1602767002_R001_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268764/GSM268764_1602767002_R001_C005_Red.xml.gz","526"
"GSM268765","Patient 587 Core Set (custom panel)","GSM268765","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 46.1","Revised Gleason Score: 7","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.364134154688569","Second Rising PSA (ng/ml): 0.6","Time (yrs) from RRP to second rising PSA: 0.695414099931554","PSA Slope (ng/ml/yr): 1.20743801652893","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.3333333333333","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-587","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268765/GSM268765_1602767002_R001_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268765/GSM268765_1602767002_R001_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268765/GSM268765_1602767002_R001_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268765/GSM268765_1602767002_R001_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268765/GSM268765_1602767002_R001_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268765/GSM268765_1602767002_R001_C006_Red.xml.gz","526"
"GSM268766","Patient 595 Core Set (custom panel)","GSM268766","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 66","PSA (ng/ml) at RRP: 7.2","Revised Gleason Score: 7","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 6.70773442847365","Second Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to second rising PSA: 7.35386721423682","PSA Slope (ng/ml/yr): 0.309533898305085","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.5147159479808","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-595","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268766/GSM268766_1602767002_R001_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268766/GSM268766_1602767002_R001_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268766/GSM268766_1602767002_R001_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268766/GSM268766_1602767002_R001_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268766/GSM268766_1602767002_R001_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268766/GSM268766_1602767002_R001_C007_Red.xml.gz","526"
"GSM268767","Patient 612 Core Set (custom panel)","GSM268767","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 13.1","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 11.6440793976728","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-612","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268767/GSM268767_1602767002_R001_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268767/GSM268767_1602767002_R001_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268767/GSM268767_1602767002_R001_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268767/GSM268767_1602767002_R001_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268767/GSM268767_1602767002_R001_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268767/GSM268767_1602767002_R001_C009_Red.xml.gz","526"
"GSM268768","Patient 620 Core Set (custom panel)","GSM268768","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: val","Age (yrs) at RRP: 63","PSA (ng/ml) at RRP: 10.7","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.21","Time (yrs) from RRP to first rising PSA: 2.30800821355236","Second Rising PSA (ng/ml): 0.42","Time (yrs) from RRP to second rising PSA: 3.61943874058864","PSA Slope (ng/ml/yr): 0.160130480167015","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.91375770020534","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-620","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268768/GSM268768_1602767002_R001_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268768/GSM268768_1602767002_R001_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268768/GSM268768_1602767002_R001_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268768/GSM268768_1602767002_R001_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268768/GSM268768_1602767002_R001_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268768/GSM268768_1602767002_R001_C010_Red.xml.gz","526"
"GSM268769","Patient 635 Core Set (custom panel)","GSM268769","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 69","PSA (ng/ml) at RRP: 12.8","Revised Gleason Score: 9","Stage: TxN+","Ploidy: diploid","First Rising PSA (ng/ml): 1","Time (yrs) from RRP to first rising PSA: 2.27515400410678","Second Rising PSA (ng/ml): 2.2","Time (yrs) from RRP to second rising PSA: 2.3791923340178","PSA Slope (ng/ml/yr): 11.5342105263158","Time (yrs) from PSA recurrence to systemic disease: 2.78165639972621","Years of Followup after RRP: 7.01984941820671","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-635","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268769/GSM268769_1602767002_R001_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268769/GSM268769_1602767002_R001_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268769/GSM268769_1602767002_R001_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268769/GSM268769_1602767002_R001_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268769/GSM268769_1602767002_R001_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268769/GSM268769_1602767002_R001_C012_Red.xml.gz","526"
"GSM268770","Patient 555 Core Set (custom panel)","GSM268770","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 23.3","Revised Gleason Score: 9","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 8.1","Time (yrs) from RRP to first rising PSA: 0.0903490759753593","Second Rising PSA (ng/ml): 9.3","Time (yrs) from RRP to second rising PSA: 0.158795345653662","PSA Slope (ng/ml/yr): 17.532","Time (yrs) from PSA recurrence to systemic disease: 5.76317590691307","Years of Followup after RRP: 12.5119780971937","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-555","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268770/GSM268770_1602767002_R002_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268770/GSM268770_1602767002_R002_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268770/GSM268770_1602767002_R002_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268770/GSM268770_1602767002_R002_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268770/GSM268770_1602767002_R002_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268770/GSM268770_1602767002_R002_C002_Red.xml.gz","526"
"GSM268771","Patient 563 Core Set (custom panel)","GSM268771","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 54","PSA (ng/ml) at RRP: 9.9","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 8.92813141683778","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-563","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268771/GSM268771_1602767002_R002_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268771/GSM268771_1602767002_R002_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268771/GSM268771_1602767002_R002_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268771/GSM268771_1602767002_R002_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268771/GSM268771_1602767002_R002_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268771/GSM268771_1602767002_R002_C003_Red.xml.gz","526"
"GSM268772","Patient 571 Core Set (custom panel)","GSM268772","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 58","PSA (ng/ml) at RRP: 4.8","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 13.1772758384668","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-571","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268772/GSM268772_1602767002_R002_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268772/GSM268772_1602767002_R002_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268772/GSM268772_1602767002_R002_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268772/GSM268772_1602767002_R002_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268772/GSM268772_1602767002_R002_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268772/GSM268772_1602767002_R002_C004_Red.xml.gz","526"
"GSM268773","Patient 579 Core Set (custom panel)","GSM268773","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: val","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 26.1","Revised Gleason Score: 8","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.2354551676934","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-579","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268773/GSM268773_1602767002_R002_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268773/GSM268773_1602767002_R002_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268773/GSM268773_1602767002_R002_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268773/GSM268773_1602767002_R002_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268773/GSM268773_1602767002_R002_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268773/GSM268773_1602767002_R002_C005_Red.xml.gz","526"
"GSM268774","Patient 588 Core Set (custom panel)","GSM268774","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 65","PSA (ng/ml) at RRP: 7.7","Revised Gleason Score: 9","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.33","Time (yrs) from RRP to first rising PSA: 0.26009582477755","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 0.432580424366872","PSA Slope (ng/ml/yr): 0.985595238095238","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 4.8186173853525","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-588","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268774/GSM268774_1602767002_R002_C006_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268774/GSM268774_1602767002_R002_C006_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268774/GSM268774_1602767002_R002_C006_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268774/GSM268774_1602767002_R002_C006_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268774/GSM268774_1602767002_R002_C006_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268774/GSM268774_1602767002_R002_C006_Red.xml.gz","526"
"GSM268775","Patient 596 Core Set (custom panel)","GSM268775","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 6.7","Revised Gleason Score: 7","Stage: T2N0","Ploidy: tetraploid","First Rising PSA (ng/ml): 0.22","Time (yrs) from RRP to first rising PSA: 5.77686516084873","Second Rising PSA (ng/ml): 0.28","Time (yrs) from RRP to second rising PSA: 6.19301848049281","PSA Slope (ng/ml/yr): 0.144177631578947","Time (yrs) from PSA recurrence to systemic disease: 4.80492813141684","Years of Followup after RRP: 11.917864476386","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-596","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268775/GSM268775_1602767002_R002_C007_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268775/GSM268775_1602767002_R002_C007_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268775/GSM268775_1602767002_R002_C007_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268775/GSM268775_1602767002_R002_C007_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268775/GSM268775_1602767002_R002_C007_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268775/GSM268775_1602767002_R002_C007_Red.xml.gz","526"
"GSM268776","Patient 604 Core Set (custom panel)","GSM268776","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 6.4","Revised Gleason Score: 8","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 0.550308008213552","Second Rising PSA (ng/ml): 0.8","Time (yrs) from RRP to second rising PSA: 1.02943189596167","PSA Slope (ng/ml/yr): 1.25228571428571","Time (yrs) from PSA recurrence to systemic disease: 0.525667351129363","Years of Followup after RRP: 10.031485284052","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-604","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268776/GSM268776_1602767002_R002_C008_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268776/GSM268776_1602767002_R002_C008_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268776/GSM268776_1602767002_R002_C008_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268776/GSM268776_1602767002_R002_C008_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268776/GSM268776_1602767002_R002_C008_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268776/GSM268776_1602767002_R002_C008_Red.xml.gz","526"
"GSM268777","Patient 613 Core Set (custom panel)","GSM268777","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 67","PSA (ng/ml) at RRP: 39.7","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.4","Time (yrs) from RRP to first rising PSA: 1.53319644079398","Second Rising PSA (ng/ml): 0.5","Time (yrs) from RRP to second rising PSA: 2.03148528405202","PSA Slope (ng/ml/yr): 0.200686813186813","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.0417522245038","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-613","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268777/GSM268777_1602767002_R002_C009_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268777/GSM268777_1602767002_R002_C009_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268777/GSM268777_1602767002_R002_C009_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268777/GSM268777_1602767002_R002_C009_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268777/GSM268777_1602767002_R002_C009_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268777/GSM268777_1602767002_R002_C009_Red.xml.gz","526"
"GSM268778","Patient 621 Core Set (custom panel)","GSM268778","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 55","PSA (ng/ml) at RRP: 2","Revised Gleason Score: 9","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 15.2197125256674","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-621","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268778/GSM268778_1602767002_R002_C010_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268778/GSM268778_1602767002_R002_C010_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268778/GSM268778_1602767002_R002_C010_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268778/GSM268778_1602767002_R002_C010_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268778/GSM268778_1602767002_R002_C010_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268778/GSM268778_1602767002_R002_C010_Red.xml.gz","526"
"GSM268779","Patient 628 Core Set (custom panel)","GSM268779","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: NA","Revised Gleason Score: 7","Stage: T2N0","Ploidy: aneuploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 16.1177275838467","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-628","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268779/GSM268779_1602767002_R002_C011_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268779/GSM268779_1602767002_R002_C011_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268779/GSM268779_1602767002_R002_C011_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268779/GSM268779_1602767002_R002_C011_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268779/GSM268779_1602767002_R002_C011_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268779/GSM268779_1602767002_R002_C011_Red.xml.gz","526"
"GSM268780","Patient 636 Core Set (custom panel)","GSM268780","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 70","PSA (ng/ml) at RRP: 37.1","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: tetraploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 7.93429158110883","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-636","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268780/GSM268780_1602767002_R002_C012_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268780/GSM268780_1602767002_R002_C012_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268780/GSM268780_1602767002_R002_C012_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268780/GSM268780_1602767002_R002_C012_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268780/GSM268780_1602767002_R002_C012_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268780/GSM268780_1602767002_R002_C012_Red.xml.gz","526"
"GSM268781","Patient 556 Core Set (custom panel)","GSM268781","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: NED","Training or Validation: trn","Age (yrs) at RRP: 62","PSA (ng/ml) at RRP: 8.1","Revised Gleason Score: 7","Stage: T2N0","Ploidy: diploid","First Rising PSA (ng/ml): NA","Time (yrs) from RRP to first rising PSA: NA","Second Rising PSA (ng/ml): NA","Time (yrs) from RRP to second rising PSA: NA","PSA Slope (ng/ml/yr): NA","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 14.0068446269678","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-556","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268781/GSM268781_1602767002_R003_C002_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268781/GSM268781_1602767002_R003_C002_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268781/GSM268781_1602767002_R003_C002_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268781/GSM268781_1602767002_R003_C002_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268781/GSM268781_1602767002_R003_C002_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268781/GSM268781_1602767002_R003_C002_Red.xml.gz","526"
"GSM268782","Patient 564 Core Set (custom panel)","GSM268782","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: PSA","Training or Validation: trn","Age (yrs) at RRP: 72","PSA (ng/ml) at RRP: 16.5","Revised Gleason Score: 7","Stage: T3bN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 3.29637234770705","Second Rising PSA (ng/ml): 0.7","Time (yrs) from RRP to second rising PSA: 3.38945927446954","PSA Slope (ng/ml/yr): 5.37132352941176","Time (yrs) from PSA recurrence to systemic disease: NA","Years of Followup after RRP: 9.47296372347707","patient's status: Alive","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-564","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268782/GSM268782_1602767002_R003_C003_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268782/GSM268782_1602767002_R003_C003_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268782/GSM268782_1602767002_R003_C003_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268782/GSM268782_1602767002_R003_C003_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268782/GSM268782_1602767002_R003_C003_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268782/GSM268782_1602767002_R003_C003_Red.xml.gz","526"
"GSM268783","Patient 572 Core Set (custom panel)","GSM268783","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: trn","Age (yrs) at RRP: 73","PSA (ng/ml) at RRP: 12.8","Revised Gleason Score: 9","Stage: TxN+","Ploidy: tetraploid","First Rising PSA (ng/ml): 2.5","Time (yrs) from RRP to first rising PSA: 4.43805612594114","Second Rising PSA (ng/ml): 6.5","Time (yrs) from RRP to second rising PSA: 4.67898699520876","PSA Slope (ng/ml/yr): 16.6022727272727","Time (yrs) from PSA recurrence to systemic disease: 1.05681040383299","Years of Followup after RRP: 7.30184804928131","patient's status: Deceased","Prostate cancer specific death: Yes","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-572","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268783/GSM268783_1602767002_R003_C004_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268783/GSM268783_1602767002_R003_C004_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268783/GSM268783_1602767002_R003_C004_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268783/GSM268783_1602767002_R003_C004_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268783/GSM268783_1602767002_R003_C004_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268783/GSM268783_1602767002_R003_C004_Red.xml.gz","526"
"GSM268784","Patient 580 Core Set (custom panel)","GSM268784","Public on Jun 10 2008","Feb 26 2008","Jun 10 2008","RNA","1","primary prostate cancer","Homo sapiens","Case-Control Group: Systemic","Training or Validation: val","Age (yrs) at RRP: 60","PSA (ng/ml) at RRP: 20.5","Revised Gleason Score: 8","Stage: T3aN0","Ploidy: diploid","First Rising PSA (ng/ml): 0.2","Time (yrs) from RRP to first rising PSA: 6.19028062970568","Second Rising PSA (ng/ml): 1.4","Time (yrs) from RRP to second rising PSA: 8.3066392881588","PSA Slope (ng/ml/yr): 0.567011642949547","Time (yrs) from PSA recurrence to systemic disease: 1.9958932238193","Years of Followup after RRP: 12.8405201916496","patient's status: Deceased","Prostate cancer specific death: No","total RNA","Four freshly cut 10 micron sections of FFPE tissue were deparaffinized and the Gleason dominant cancer focus was macrodissected. RNA was extracted using the High Pure RNA Paraffin Kit from Roche (Indianapolis, IN).","cy3, cy5","cy3, cy5 labeling was performed in accordance with the manufacturer's instructions","9606","hybridization was performed in accordance with the manufacturer's instructions","Arrays were scanned using Illumina's BeadArray Reader","TNPr-580","Illumina's Bead Studio Software using no normalization was used to process the image files. The raw data was then normalized using cyclic loess (fastlo). The normalized value for the probes was averaged to determine the expression level for the gene. The DASL method labels each sample with a mixture of CY3 and Cy5. Only a single sample is applied to each array.  The scanner measures fluorescence of both Cy3 and Cy5.  This data is contained in the red and grn files for each sample. The bead studio software averages the red and green signals to provide a single value for the expression of a particular probe.","GPL5873","Robert,B.,Jenkins","rjenkins@mayo.edu","Laboratory Medicine and Pathology","Mayo Clinic","200 First Street SW","Rochester","MN","55905","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268784/GSM268784_1602767002_R003_C005_Grn.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268784/GSM268784_1602767002_R003_C005_Grn.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268784/GSM268784_1602767002_R003_C005_Grn.xml.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268784/GSM268784_1602767002_R003_C005_Red.idat.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268784/GSM268784_1602767002_R003_C005_Red.jpg.gz","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM268nnn/GSM268784/GSM268784_1602767002_R003_C005_Red.xml.gz","526"
